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Gametogenesis is one of the most important biological processes in the life of an organism 
because it results in the production of gametes, haploid cells that pass on the organism’s genetic 
material to its offspring. However, it a very complicated, intricate process that demands a very 
high level of regulation. This regulation is to ensure error free meiotic and post-meiotic divisions 
resulting in a haploid gamete. Errors during the meiotic process can result in defective embryos 
or fetal demise. Among mammals, humans exhibit a very high rate of gamete defects (~25%) 
leading to high rates of early embryo loss.  
Stage-specific cell signaling cascades such as the MAPK pathway regulate meiosis and germ-cell 
development. In addition to this, MAPKs specifically ERKs, are thought to be involved in 
cellular division, cytoskeletal reorganization and segregation of genetic material. So far 
pharmacological approaches have been used to study the action of ERKs in oocytes in vitro 
using inhibitors of the ERK pathway. However, these are not truly reflective of the physiological 
environment of the ovary. Hence, in order to better understand the mechanism of action of ERKs 
on oocyte division, I have generated an Erk2 conditional deletion system driven by an oocyte 
specific Cre on an Erk1 null background. I hypothesized that deregulation of the MAPK pathway 
in oocytes will produce drastic changes in the cytokinesis and in chromosome segregation.  
Mutant females were found to be infertile, with gross chromosome misalignment on metaphase 
spindles in oocytes, and severe early embryonic loss. This phenotype was accompanied by loss 
of phosphorylation of several downstream targets such as MSK1 and histone H3. Several 
possible new targets have also been identified in this study by comparing phosphrylation profiles 
of oocytes from various genotypes. Our results demonstrate that ERK activity specifically within 
the oocyte is essential for meiotic resumption and for normal pre-implantation development. 
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CHAPTER 1 
Germ cell development and gene networks 
 
This work has been published as Chapter 3. Gene Networks in Oocyte Meiosis. In Alan 
Trounson, Roger Gosden, Ursula Eichenlaub-Ritter (2013) Biology and Pathology of the 
Oocyte: Role in Fertility, Medicine and Nuclear Reprogramming. 2nd Edition. Cambridge 
University Press. Sections marked with * are not included in the original book chapter. 
 
1. Abstract 
In the current era of the genome, the amount of information available about gene expression, 
protein products, their interactions and pathways in almost any physiological system has become 
quite overwhelming.  The processes of mammalian meiosis and oocyte development are no 
exception. Most of these data have been generated using high throughput genomic and proteomic 
screening systems. However, various experimental approaches over several decades, such as 
targeted mutagenesis, modification/suppression of specific genes both in vivo and in vitro, have 
also contributed greatly to our understanding of the genetic basis for meiotic processes and 
oogenesis (Martin and Drubin 2003). Such studies have also been greatly enhanced using 
comparative analyses of these processes across the animal kingdom, allowing us to identify key 
genetic pathways that are functionally conserved in germ cells.  With all the available 
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information from multiple online databases, gaining an understanding of a complex process like 
meiosis, that spans several years and involves numerous cellular pathways, is challenging. It is 
especially difficult when trying to obtain a view that encompasses both the cellular events of 
meiosis, yet also puts these processes in the context of the overall physiology and systems 
biology of the ovary. Representation of biological interactions within the cell in terms of gene 
networks provides an accurate and explanatory basis for studying cellular events.  In addition, 
creating gene networks, by its very nature, helps us to define common processes amongst many 
different species, allowing us to appreciate both the similarities and the differences in these 
processes across the animal kingdom.  At the same time, we can identify commonalities among 
cellular processes in terms of the networks that they utilize.  
2. Introduction to gene networks  
Gene networks are defined as graphs showing multiple genes as intersection points of lines that 
represent the interaction between these points (Rapaport, Zinovyev et al. 2007). These can 
represent direct gene product interactions, such as protein-protein interactions, or indirect 
interactions corresponding to successive steps of a metabolic pathway (Table 1). Interactions can 
also arise between genes themselves causing an up-regulation or suppression of activity (protein-
DNA interaction). These interactions can be useful in predicting changes in expression patterns 
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and/ or change in metabolic pathways of other genes that are closer in the network to the gene of 
interest. This is extremely useful in creating a detailed biological model of cell-cell interactions, 
pathways and roles of genes in specific cellular pathways within a tissue without having to 
determine the action of each individual gene one-by-one (D'Haeseleer 2005). Networks can also 
be used to predict the function of previously unknown genes if they are identified to be a part of 
known gene clusters with high-confidence interconnections (Cohen and Holloway 2010).  
A gene network is created by integrating many different criteria such as temporal gene 
expression, physical interaction of products, protein domains, comparative expression patterns in 
taxonomically close organisms (phylogeny), contribution to similar pathology and participation 
in connected biological processes (gene ontology) (Cohen and Holloway 2010). Some of these 
criteria are obtained by wet-bench experimentation (expression profiles etc.), while others can be 
obtained in silico (by computational means: gene similarities, common functional motifs etc.). 
Many databases are becoming available for collating such data across large gene sets, often 
linked to the genome browser sites (Table 2).  Collectively, all these features are assigned 
quantitative values and their combined measurement gives an idea of the strength of functional 
association of a group of genes. Such data sets are then analyzed by different methods like 
cluster analysis, correlation analysis and analysis of mutual information (Hallinan, James et al. 
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2011). The resulting data is then used as a resource to highlight groups of genes over-represented 
in a particular cell type at specific times and subsequently to understand the mechanisms driving 
the development and function of that cell type/ tissue.  
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Table 1.1. Common interactions in a network 
 
Physical interactions 
Interaction type      Example 
• Between components found in the    Membrane fusion proteins 
same cellular compartment     and cargo binding proteins 
        in secretory vesicles 
• Part of the same macromolecular structure    Structural proteins forming 
        the meiotic spindle 
• Produced at about the same time in the cell cycle   Proteins required for gap 
        junction closure in cumulus- 
        oocyte complex and proteins 
        for phosphodiesterase  
                   activity in the oocyte 
Functional interactions 
Interaction type      Example 
• Found in the same cellular pathway       DNA repair proteins 
• Genetic interactions      Proteins involved in of the 
        epigenetic reprogramming 
        oocyte during development 
• Producing similar tissue expression patterns               Retinoic acid response         
(in analogous processes across cell types or   elements expression in 
between species)      testicular tissue 
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• Taking part in the same functional process    Chemotactic proteins and 
        extracellular matrix proteins 
        both regulating germ cell 
        migration 
Table 1.2: More commonly used databases for observing biological themes in expression 
patterns 
 
  
 
Database Description  
Gene ontology 
http://www.geneontology.org/ 
Gene and gene product functions across species at 
biological, cellular and molecular levels 
NCBI Gene Entrez 
http://www.ncbi.nlm.nih.gov/gene 
Gene and protein sequences, structures, chromosome maps, 
references 
Kyoto Encyclopdia of Genes and 
Genomes(KEGG) 
http://www.genome.jp/kegg/ 
Genomes, biological pathways, molecular interactions, 
diseases and drug development 
OMIM 
http://www.ncbi.nlm.nih.gov/omim 
Catalog of human diseases with known genetic components 
UniProt database 
http://www.uniprot.org/ 
Protein function, cellular localization, interactions, 
expression patterns, domains 
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 3. Germ cell development 
The formation of germ cells and their commitment to either one of two sex-specific 
developmental pathways (oogenesis or spermatogenesis) occurs during fetal life in mammalian 
species. In the mouse and human, cells in the germ cell lineage arise from the epiblast region of 
the embryo, closest to the extra-embryonic ectoderm (Acevedo and Smith 2005). These cells 
acquire the competence to form primordial germ cells (PGCs) but only a subset of them actually 
go on to become PGCs (Ewen and Koopman 2010).  
3.1 Competence to form PGCs 
Competence to enter the PGC specification pathway occurs under the influence of factors such as 
BMP4 and BMP8b, which are expressed by cells of the surrounding extra-embryonic ectoderm 
(Amleh and Dean 2002; Acevedo and Smith 2005). These factors induce the expression of genes 
in the Fragilis family, such as Ifitm3 (Fragilis), Ifitm1(Fragilis2) and Ifitm2(Fragilis3) in the 
PGC precursor cells, which may play a role in germ cell adhesion and specification (Ewen and 
Koopman 2010). A subset of the PGC precursor cells also begin expression of Blimp1 (Prdm1). 
It is these cells specifically, that are destined for the PGC fate (Hayashi, de Sousa Lopes et al. 
2007). BLIMP1 is a key factor in regulating PGC specification of cells characterized by the 
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repression of somatic genes and upregulation of germ cell specific genes like Prdm14, Ssea1, 
Tnap and Tiar.  
Ifitm3 is responsible for the production of Fragilis protein in the mouse, which then induces the 
expression of a germ-cell specific gene Stella(Dppa3) that is involved in chromosome 
organization and RNA processing and allows the PGCs to retain pluripotency (Hayashi, de Sousa 
Lopes et al. 2007). Retention of pluripotency in the PGCs is accompanied by the expression of 
stem cell-associated markers including Nanog, Oct4 and Sox2, which are initially seen only in 
the very early embryo, and which are then re-expressed in the mouse PGCs by Embryonic day 
7.25 (E7.25) (Hayashi, de Sousa Lopes et al. 2007). However, transcripts of Oct4 have been 
detected in the mouse epiblast as early as E6.5. Oct4, in addition to maintaining pluripotency, is 
needed for the survival of the PGCs, which may explain its relatively early expression (Oktem 
and Urman 2010). In addition to this Blimp1 and Smad1 expression has been implicated in 
suppression of genes required for setting up somatic cell lineage like Hoxb, Fgf8 and Snail 
(Combes A 2010).  
3.2 Migration and colonization of the fetal gonad 
The PGCs migrate from the extra-embryonic mesoderm to the urogenital ridge of the embryo at 
E10 in mice and about third week of gestation in humans (Amleh and Dean 2002). This 
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migration is mediated by the interaction between c-kit, a tyrosine kinase receptor located on the 
surface of PGCs and its ligand, KitL, located on the somatic cells along the migratory pathway. 
The expression of c-kit/W in the PGCs and Kitl in the somatic cells therefore, is high at this time 
(Zheng and Dean 2007) as are several somatic cell signals necessary to regulate PGC motility 
like SDF1 and PECAM1 (Ewen and Koopman 2010). At the same time, the PGCs themselves 
express a variety of genes, including Mvh, Dnd, Dazl1 and Nanos3, all of which assist in 
maintaining germ cell lineage during this migration (Oktem and Urman 2010; Wang, Kou et al. 
2010).  
After migration to, and colonization of, the genital ridges, new interactions with the surrounding 
somatic cells of the indifferent gonad induces expression of genes in the germ cells encoding 
adhesion molecules (ADAM family) (Combes A 2010). The PGCs proliferate rapidly under the 
influence of several proliferation signals from genes such as Cxcr4, Pin1, Ssea1, Wt1, Nanos3 
and LIF receptor (Ewen and Koopman 2010; Rolland, Lehmann et al. 2011).   Surrounding 
somatic cells also initiate several paracrine mechanisms with factors such as TNFa, SDF1 FGF2, 
FGF4 and FGF8 to ensure the survival and proliferation of the PGCs in their new environment 
(Ewen and Koopman 2010). Expression of some germ cell markers decreases (Tnap, Prdm1, 
Ssea1) at this time, accompanied by a reduction in ability to form pluripotent stem cells, at least 
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in culture (Combes A 2010; Rolland, Lehmann et al. 2011). Concomitantly, expression analysis 
on fetal gonads in mice (E11-18) shows higher expression of a group of 37 genes, which include 
known pluripotency markers like Dppa2, Nanog, Oct4 and Sox2, along with other genes that 
regulate meiotic entry and germ cell differentiation, including Ddx4, Gcna1, Dazl and Gcl 
(Rolland, Lehmann et al. 2011). These expression changes are accompanied by widespread 
epigenetic reprogramming in the form of genome demethylation and chromatin remodeling 
(Rolland, Lehmann et al. 2011), with some hundred or so genes undergoing this type of 
imprinting in the females. At this time the non-germ cell populations in the gonad have 
bipotential, having the ability to develop into Sertoli or granulosa cells (Combes A 2010).    
The germ cells colonizing the female gonadal ridges (now known as the oogonia at around E9.5) 
are initially present as cell clusters connected by cytoplasmic bridges, which after complete 
cytokinesis become surrounded by pre-granulosa cells, thereby forming the first primordial 
follicles. Figα expression in the oogonia is shown to be required for this process (Combes A 
2010). Gene network analysis of mouse oogonia showed overexpression of some 500 or so 
genes. GO annotation analysis revealed their involvement in biological processes such as germ 
cell development, DNA methylation, ovarian follicle development and meiosis (Rolland, 
Lehmann et al. 2011). 
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4. Sex determination 
Mouse fetal gonads at E12 start showing sexual dimorphism, which is initiated by the somatic 
cell environment of the germ cells. Sexual differentiation of the somatic component of the gonad 
is followed by differentiation of the germ cells, which involves an upregulation of several genes 
in both the male and female gonad. About 250 of these genes are germ cell specific while close 
to 1700 genes are in the somatic cells. Of these genes, female bias is shown by group containing 
Bmp2, Fst and Wnt4 genes whereas Sox9, Amh and Cyp26b1 showed male-biased expression. 
After E12 some 60 genes have been shown to have female specific expression. Some of these are 
meiosis specific genes like Dmc1 and Spo11 indicating the achievement of meiotic competence 
in female germ cells immediately after colonizing the gonads (Combes A 2010). Furthermore, 
this same group of genes was highly expressed in post-natal testis only at the beginning of 
spermatogenesis although both XX and XY germ cells have been shown to be meiotically 
competent in culture at this stage (Combes A 2010; Rolland, Lehmann et al. 2011). 
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Figure 1.1. Genes expressed for primordial germ cell (PGC) development in the mouse 
Gene names above the dotted line are expressed in the germ cell and below the dotted line are 
observed in the somatic cell population. Germ cell specification begins in the extra embryonic 
ectoderm when cells in the proximal epiblast acquire competence to form PGCs (PGC precursor 
cells). A subset of these cells then goes on to have PGC fate later on in development. Both these 
steps of specification are the effect of paracrine signals from the surrounding cells of the extra-
embryonic ectoderm such as proteins from TGFβ, BMP and SMAD families. These signals 
induce the expression of genes involved in the germline fate allocation of the cells expressing 
them. Simultaneously, the PGCs also express genes required for maintaining the pluripotency 
potential and for suppression of a somatic cell fate. The next step in PGC development is their 
migration from the specification site along the hindgut through the dorsal mesentery to the 
genital ridges on either side. This process is mediated by somatic cell- derived signals for 
motility such as Kit-Ligand factor (encoded by Steel) and signals for chemotaxis such as SDF1 
(encoded by Sdf1) and adhesion molecules such as those of the ADAM family. Colonization of 
the genital ridges is mediated by the expression of germ cell specific factors (Gcna1, Ddx4), 
which is followed by epigenetic reprogramming (Blimp1, Prmt5) which sends the germ cells to a 
fate of meiotic competence. The timescale is as per embryonic development in the female mouse. 
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5. Entry into, and progression through, Meiotic prophase I during fetal life 
5.1 Entry into the meiotic pathway 
In female embryos, entry into meiosis is marked by, and dependent on, up-regulation of retinoic 
acid (RA) response genes, including Stra8 (Combes A 2010), while PGCs from male embryos 
express genes that are required for RA degradation, thus preventing meiotic entry at this time 
(Koubova, Menke et al. 2006).  In females, germ cells at this stage are called primary oocytes. 
Stra8 expression is required for pre-meiotic DNA replication, chromosome condensation and 
occurs at E12-13 in mice and 8-13 weeks of gestation in humans (Combes A 2010). At the same 
time, the RNA binding factor, Dazl, is also expressed, and this appears to be essential for germ 
cell specification of sexual fate in both males and females (Gill, Hu et al. 2011).  Dazl expression 
is co-incident with expression of at least 13 other genes, including some that code for translation 
factors (Eif3g, Eif4b, Eif4h), and other RNA binding proteins (Igf2bp1, Cpeb2) (Zheng, 
Griswold et al. 2010), collectively suggesting a requirement for RNA involvement and/or control 
of translation in germ cell specification. Here, once again, gene ontology can provide vital clues 
as to the functional requirements for a given process. 
RA is a metabolite of vitamin A, and is essential for the development of several tissues in the 
embryo (Griswold, Hogarth et al. 2012). RA is synthesized by the oxidative metabolism of 
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Retinol by retinaldehyde dehydrogenases. It acts through two nuclear receptors, RAR (Retinoic 
acid Receptor) and RXR (Retinoic X Receptor) to activate RA response elements (RARE) in 
target genes to modulate their transcriptional activity (Combes A 2010; Griswold, Hogarth et al. 
2012). RA is degraded by enzymes in the cytochrome p-450 family (CYP26A1, CYP26B1, 
CYP26C1), which help to regulate RA levels within a tissue (Combes A 2010). One of the main 
gene targets of RA within the gonad is Stra8, which is expressed in the mouse fetal ovary as 
early as E12.5 whereas its expression in the testis is delayed until 10 dpp (10 days post-partum). 
Up until that time, endogenous RA is constantly degraded in the testis by CYP26B1 (Combes A 
2010). Studies performed on embryonic mouse gonads show that both exogenous and 
endogenous RAs as well as several RARs (RARα, RARβ, RARγ) can induce Stra8 expression in 
Vitamin A deficient mice, indicating the role of RA in regulating Stra8 function (Koubova, 
Menke et al. 2006; Griswold, Hogarth et al. 2012).  
Stra8 is upstream of pre-meiotic DNA replication, and analysis of Stra8 null mice demonstrates 
its requirement in meiotic initiation during both spermatogenesis and oogenesis (Anderson, 
Baltus et al. 2008). However Stra8 is only one of the genes in the transcriptome profile of RA 
response genes in mouse gonads. While this list contains genes known to be involved in meiosis, 
such as Slc25a31, Tex15 and Rad51, other genes with as yet unknown functions in meiosis 
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(Esco2, Setdb2, Uba6) have been found to be highly up-regulated directly or indirectly in 
response to RA (Hogarth, Mitchell et al. 2011). ESCO2 is involved in sister chromatid cohesion, 
whereas SETDB2 and another SET family protein SUV39H2 have been implicated in chromatin 
remodeling in germ cells (Hogarth, Mitchell et al. 2011). UBA6 is a protein in the ubiquitylation 
pathway (Hogarth, Mitchell et al. 2011). These genes have been implicated in meiotic initiation 
only in the male germ cells so far and their functions in females are yet to be identified. However 
their presence downstream of RA in males, together with the timing of expression would, in 
predictive network analysis, make them solid candidates for oocyte RA responses too. 
There appears to be some crosstalk between the RA response pathway and other pathways for 
meiotic initiation. Homeobox transcription factors Msx1 and Msx2 can be up-regulated by RA, as 
well as Bone Morphogenic Proteins BMP4 and BMP2, have been shown to regulate Stra8 
expression in mouse fetal ovary, but not the testis (Le Bouffant, Souquet et al. 2011). The DM 
domain gene Dmrt1 known to be required for testicular differentiation is required for 
transcriptional activation of Stra8 in the mouse fetal ovary, however, the process maybe 
independent of RA (Krentz, Murphy et al. 2011).  
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5.2 Initiation of meiosis and Prophase I 
Meiosis initiates soon after DNA replication, with entry into prophase I. Prophase I is subdivided 
into five stages – Leptonema, Zygonema, Pachynema, Diplonema and Diakinesis.  Prophase I 
encompasses all the defining features of meiosis, namely the pairing and physical association (or 
synapsis) of homologous chromosomes, formation of the synaptonemal complex and the 
initiation of recombination events between them (crossing over). In the perinatal female mouse, 
oocytes then enter a prolonged diakinesis state known as dictyate arrest, in which meiosis I halts, 
only to resume following puberty in response to the LH surge that triggers ovulation (Morelli 
and Cohen 2005; Handel and Schimenti 2010). The synaptonemal complex (SC), the most 
characteristic feature of prophase I, is a tripartite proteinaceous structure that binds homologous 
chromosomes together to aid recombination events between them (Handel and Schimenti 2010).  
Prophase I begins with chromosomes searching for their homologous partner based on DNA 
sequence homology (Li and Ma 2006). While it is thought that synapsis of homologous 
chromosomes is brought about by formation of single strand overhangs that then find the 
homology sequence in the partner chromosome, it is believed that a physical congregation of 
chromosomes into a structure known as the “telomere bouquet”, and the attachment of their 
telomeres to the nuclear envelope facilitates the initial alignment of homologous chromosomes 
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with each other (Handel and Schimenti 2010). In mammals, Unc84a/Sun1 expression is believed 
to play a role in the formation of these telomeric clusters at the nuclear envelope, while other 
organisms express genes that are orthologous to these SUN/KASH domain genes (Hiraoka and 
Dernburg 2009).  
The initial localization of synaptonemal complex proteins SYCP2 and SYCP3 to form axial 
elements of the SC also serves in bringing homologous chromosomes closer with their 
interactions (Handel and Schimenti 2010). These associations culminate in synapsis, where the 
two homologous chromosomes are physically held together along their entire lengths by means 
of the central element. The SC components assemble sequentially, starting with the axial 
elements, which form foci along each homologue, and these foci then coalesce to form a filament 
that eventually spans the entire length of the chromosome, with DNA loops extending 
perpendicularly from the core. The foci of axial elements are formed by grouping of SC specific 
proteins like SYCP2 and SYCP3. Cohesion proteins like SMC1B, REC8 and STAG3 localize to 
the axial elements and are believed to play a structural role in the assembly of the axial element 
(Handel and Schimenti 2010). Once pairing is established and confirmed, the central element 
then assembles, with appropriate density of DSB-induced DNA-DNA interactions between 
homologs. The central element of the SC is formed by SYCP1, SYCE1, SYCE2 and TEX12 
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which are also meiosis specific (Handel and Schimenti 2010). HORMAD1 and HORMAD2 are 
present in unsynapsed regions of axial element and may play a role in regulation of homolog 
interactions and synapsis (Handel and Schimenti 2010; Santucci-Darmanin 2010).   
 
5.3 Meiotic recombination 
Homolog pairing occurs around the same time as the formation of the double strand breaks 
(DSBs) that are of the precursors for meiotic recombination and which, in mammals at least, 
precede the process of synapsis (the physical tethering of paired homologous chromosomes). 
Recombination between homologs in a chromosome pair is under the control of several serially 
expressed genes responsible for specific events in the recombination pathway and, in its simplest 
form, represents a highly regulated DNA repair process involving many components of the DNA 
damage repair (DDR) machinery. Not surprisingly, therefore, genes that participate in DDR 
events are all expressed at high levels during prophase I, and many share overlapping functions 
with canonical repair events in somatic cells.  
DSB formation is catalyzed by the highly conserved topoisomerase SPO11 (Santucci-Darmanin 
2010). A SPO11 dimer creates DSBs in the two strands of DNA and each monomer then attaches 
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to the 5’ terminus of each strand break from where it is cleaved away by endonucleases (Keeney 
2008). SPO11 induced double strand break formation is found in almost all meiotic species 
studied to date. In Saccharomyces cervisiae Spo11 requires at least 9 other gene products in 
order to produce DSBs, only a handful of orthologs of which have been identified in mammals. 
These include components of the mammalian Mre11 complex (Xrs2, Rad50, Mre11), 
collectively known as the MRX/N complex, which tethers DNA to co-ordinate events at the two 
ends of the DSB (Keeney 2001; Santucci-Darmanin 2010). Apart from the MRX/N complex 
Mei1 has also been implicated in DSB formation and interaction with SPO11 in the mouse 
(Munroe, Bergstrom et al. 2000; Kumar, Bourbon et al. 2010).  
Following DSB formation in early leptonema, the breaks are then processed through several 
common precursor steps, for a number of possible recombination pathways. Firstly, 3’ overhangs 
are generated following 5’ end resection by an exonuclease whose identity is uncertain in 
mammals, but which appears to be primarily Exo1 in yeast (Neale, Pan et al. 2005). The RecA 
homologs, DMC1 and RAD51, bind to the single stranded overhangs and cause interaction 
between homologous chromosomes and facilitate strand invasion (Santucci-Darmanin 2010). In 
addition the protein BRCA2 is also known to be involved in DSB processing and strand 
invasion, perhaps by interacting with RAD51 and DMC1 and allow correct positioning of 
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RAD51-DMC1 foci (Li and Ma 2006). Other accessory proteins in mammals that assist the 
formation and function of RAD51-DMC1 foci are the HOP2-MND1 dimer that stabilizes these 
foci and promotes their ability to associate with DNA; and RAD54B which is thought to promote 
that strand invasion activity of DMC1 (Santucci-Darmanin 2010). In addition, mammals possess 
several Rad51 paralogs that are expressed in cells exhibiting recombination such as Rad51b, 
Rad51c, Rad51d, Xrcc2, and Xrcc3. All these genes are expressed widely during homologous 
recombination (Masson, Tarsounas et al. 2001). In vitro these proteins for a complex known as 
the BCDX2 that binds to DSBs and are believed to aid RAD51 localization there (Masson, 
Tarsounas et al. 2001).   
The next step in meiotic recombination is the processing of strand exchange by either CO 
(Crossover) or NCO (Non Crossover) pathways. Importantly, the number of CO events in 
mammals is about 10% of the number of initiating DSB events, suggesting that most of these 
DSBs are resolved by NCO, but that both CO and NCO events arise from common precursors. 
Briefly, following DSB formation and 3’ overhang strand invasion, DNA synthesis takes place 
from this 3’ end using the other chromatid as a template (Handel and Schimenti 2010). A double 
Holliday junction (dHJ) is formed as a result of ligation that are then resolved. The products can 
be either CO or NCO depending on how the Holliday junctions are resolved, but this process is 
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extremely biased towards CO fates, leading researchers to speculate on the existence of 
temporally and functionally distinct NCO pathways that can account for the over-abundance of 
NCO events. Evidence for this earlier NCO pathway, which utilizes a process known as 
synthesis-dependent strand annealing (SDSA), exists in S. cerevisiae (Ehmsen and Heyer 2008). 
CO events correspond to “Chiasmata”, which physical tethers that are essential for holding the 
two homologous chromosomes together and ensure proper segregation during anaphase 
(Santucci-Darmanin 2010). The number and distribution of COs are strictly regulated by a 
process known as CO interference, hence only a fraction of DSBs are repaired to CO products 
(Ehmsen and Heyer 2008; Handel and Schimenti 2010). In S.cerevisiae, two components of the 
synaptonemal complex axial elements, Red1 and Hop1 are involved in prevention of crossovers 
between sister chromatids. The mammalian orthologs of these, HORMAD1 and HORMAD2 are 
also found in the axial region and are believed to perform the same function (Handel and 
Schimenti 2010).  
Of the several gene products that are active in the crossover pathway in mammals, the 
mammalian orthologs of yeast ZMM proteins (a group of seven collaborating proteins) are 
involved in CO formation. MSH4 and MSH5 are proteins from this group that bind Holliday 
Junctions as a heterodimer, presumably encircling the DNA duplex and stabilizing them 
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(Santucci-Darmanin 2010). This heterodimer, named MutSg, is thought to participate in the CO 
bias for dHJ repair.  However, the number of MSH4-MSH5 foci in the mouse exceeds the 
number of actual CO sites. Two other proteins that are downstream, MLH1 and MLH3, are 
recruited sequentially to MSH4-MSH5 foci for CO events (Kolas, Svetlanov et al. 2005). Only 
those foci that are stabilized by MLH1 and MLH3 go on to become crossovers, indicating that 
the interactions of these four proteins may influence CO interference (Ehmsen and Heyer 2008). 
The fate of the other foci is not known, but these could be processed through NCO pathways, or 
through a second pathway regulated by the MUS81-EME1 complex. More recently, ubiquitin 
ligase genes, such as Rnf212 have been identified which determine recombination ‘hotspots’ in 
the genome (Holloway, Booth et al. 2008; Santucci-Darmanin 2010). The protein dimer XPF-
ERCC1, supplement the action of mismatch repair components in the repair of 
insertions/deletions that are large in size (Ehmsen and Heyer 2008). Several gene products such 
as those of Atr, Trip13, and Atm are implicated in a checkpoint mechanism that monitors DSB 
repair and synapses of chromosomes at pachynema (Handel and Schimenti 2010).  
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Fig 1.2 Gene expression during meiosis in the mammalian fetal germ cell 
In response to retinoic acid production from somatic cells in female embryonic gonad, there is an 
up-regulation of retinoic acid response genes in the germ cells, such as Stra8 and other related 
genes such as Msx1, Msx2 and Dmrt1, which facilitate the entry into meiosis in the germ cells. 
Other genes expressed at this time include Dazl as well as 13 other genes, which code for 
translation factors and RNA binding proteins. Genes expressed at this time are involved in pre-
meiotic DNA replication, after which the germ cells enter Prophase I of meiosis. Homologous 
chromosomes are brought together by the action of Unc84a, which helps tether the chromosomes 
to the nuclear envelope. The products of genes such as Spo11, Xrs2(Nbs1), Rad50, Mre11, and 
Mei1 are involved in production of double strand breaks (DSBs). DMC1 and RAD51 proteins 
bind to the single stranded overhangs and cause interaction between homologous chromosomes 
and facilitate strand invasion alongwith several other proteins that aid RAD51 localization. 
These foci are processed through various crossover and non-crossover pathways involving 
protein products of genes such as Msh4, Msh5, Mlh1, Mlh3, Mus81, and Eme1. Several gene 
products such as those of Atr, Trip13, Atm, Ercc4 and Ercc1are implicated in pachytene 
checkpoint mechanism as well as supplementing the action of mismatch repair components in 
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the repair of insertions/deletions that are large in size. After completion of recombination events 
genes such as Nek1 and Ubb are involved in cohesin removal and exit from prophase I.  
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Much of our understanding of meiotic recombination comes from studies of yeast and other 
organisms. However, since many of the genes and their functions in prophase I are highly 
conserved, we can be confident that the pathways may be similar from yeast to human. In fact, 
gene co-expression networks constructed using gene profiles from meiotic prophase microarray 
data in yeast, mouse and humans show several conserved gene modules that fall into GO 
categories like recombination, cohesion, transcription, synaptonemal complex assembly and 
pachytene (Li, Lam et al. 2010). Also, not all genes forming a network in meiotic prophase are 
meiosis specific. Known non meiosis-specific genes like Rad21, Smc3, Smc1, Mad2l1, Espl1, 
Ccna1 and Rad51 are seen to be interacting with meiosis specific genes during several steps of 
the recombination pathway (Zheng, Griswold et al. 2010). Rad21, Smc1a and Smc3 are involved 
in chromatin cohesion whereas Mad2l1 participates in spindle assembly during both mitosis and 
meiosis (Zheng, Griswold et al. 2010). The rest are involved in homologous recombination and 
mismatch repair. In a network constructed of genes conserved between human and mouse, 
several connections are found with non-meiotic genes. For instance, Sycp2 is shown to be 
connected with genes like Tex11, Tex15, Hspa41, Hsf2bp and Hormad2(Su, Li et al. 2011). Of 
these Hspa41 and Hsf2bp are heat-shock proteins while the others have unknown functions but 
have been shown to associate with unsynapsed chromosomes. Similarly, Msh4 has been shown 
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to be connected with Mtl5, a gene encoding metallothionein protein, in this network(Su, Li et al. 
2011). These observations underscore the importance of using gene regulatory networks in 
studying specifics of prophase I and also concomitant mechanisms like nuclear organization, 
DNA repair and so on. 
5.4 Meiotic recombination and aneuploidy 
In contrast to the high degree of conservation among species at the genetic and functional level, 
it is important to note that humans exhibit an unusually high (10-25%) rate of aneuploidy, 
resulting in high rates of embryonic defects and fetal demise. Unusual distribution of 
recombination events, such as formation of COs close to the telomere, presence of two or more 
COs in close proximity etc, have been associated with aneuploidy in human oocyte (Garcia-
Cruz, Roig et al. 2009). The number of MLH1 and MLH3 foci is highly heterogeneous in human 
oocyte chromosomes as compared to the mouse, suggesting the natural occurrence of 
achiasmatic chromosomes (and therefore, aneuploidy) is more frequent (Lenzi, Smith et al. 
2005). Maternal age has been the primary focus of studies on the risk of human aneuploidy along 
with environmental pollutants like bisphenol A (Hunt, Koehler et al. 2003; Garcia-Cruz, Roig et 
al. 2009). Both factors have been linked with heterogeneity of MLH1 foci as well. Studies on 
heat shock proteins like HSF1 and HSF2, whose activity is regulated by environmental stressors, 
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show that they are powerful transcriptional regulators of several gene networks in the meiotic 
pathway. This indicates that meiosis, through the action of HSFs, is heavily modulated by 
environmental conditions (Le Masson, Razak et al. 2011). Moreover, data from both mouse and 
humans indicate the involvement of less stringent checkpoint mechanisms in the female leading 
to a higher tolerance to errors (Nagaoka, Hodges et al. 2011). This implies that in humans, the 
already high tendency towards aneuploidy, combined with exposure to environmental risk 
factors and reduced regulational control, may all contribute to the high incidence of meiotic 
errors, thereby affecting the quality of reproductive health in women. 
6. Meiotic resumption after birth 
By the end of pachynema the SC begins to disassemble, allowing the homologs to move apart 
during diplonema. After this the oocytes enter what is known as the dictyate arrest (E20), which 
is a quiescent form of diplonema, and remain in this state until puberty when meiosis is resumed 
in cohorts of oocytes, under the influence of gonadotropins (Richards and Pangas 2010). Meiotic 
resumption is triggered by LH-induced EGFR pathway signals from cumulus cells resulting in 
Germinal Vesicle Breakdown (GVBD) in the oocytes followed by condensation of chromatin 
into chromosomes (Sun, Miao et al. 2009). GVBD marks the exit of the oocyte from the first 
meiotic arrest, which is then followed by completion of meiosis I, where asymmetric cytokinesis 
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after telophase I results in the formation of a small polar body that is then extruded (Sun, Miao et 
al. 2009). The oocyte then enters meiosis II, progresses to metaphase II (MII), where it is 
arrested a second time. Exit from this arrest occurs only after fertilization followed by 
completion of meiosis II and extrusion of a second polar body (Sun, Miao et al. 2009). These 
events are used to categorize oocytes into three important and physiologically distinct stages of 
post-prophase development namely, GV stage (prior to onset of meiotic resumption), MI (during 
completion of meiosis; “reactivated” oocytes) and MII (at arrest prior to fertilization) (Wang, 
Kou et al. 2010). Developing GV stage oocytes accumulate resources required for the 
resumption from dictyate arrest and completion of meiosis whereas the MII stage oocyte 
accumulates resources required for fertilization, oocyte to zygote transition and early cleavage 
divisions of the embryo. Transcriptome profiling of these different stages provide great insight 
into the processes regulating development of an immature oocyte and its transformation to an 
embryo (Zhang, Zucchelli et al. 2009). 
Developing oocytes in growing follicles accumulate mRNA transcripts and proteins required for 
later functions during fertilization and first cleavage divisions. Transcriptional activity is lower 
in oocytes that have reached their maximum size and progressively decreases with each step of 
the oocyte maturation with the lowest gene expression in the MII oocyte (Assou, Anahory et al. 
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2006). Of the many genes in the same GO categories expressed in both GV and MII stages, such 
as metabolism and cell communication, the proportion of genes in individual categories is higher 
in GV stage (Assou, Anahory et al. 2006; Fair, Carter et al. 2007). However, oocytes undergoing 
meiotic resumption have been shown to have gene expression profiles that are stage-specific. A 
stage-by-stage analysis of human oocyte mRNA transcripts and their GO categorization showed 
the total number of expressed genes declined from 10869 in GV oocytes to 9682 in MI and 5633 
in MII oocytes. While a large number of genes (444) were overexpressed in MII oocytes there 
was an increase in the number of genes that were under expressed (803) specifically at this stage. 
This demonstrates that the transcriptional activity is higher in oocytes earlier in meiotic 
resumption, leading to production and storage of transcripts required for completion of meiosis, 
fertilization and early cleavage divisions. 
Similar global gene expression analysis from mRNA transcripts of bovine oocytes undergoing 
meiotic resumption and maturation showed over 800 genes that are differentially expressed 
between GV and MII oocytes out of a total of 8000 expressed genes (Fair, Carter et al. 2007). 
With mouse oocytes, the global gene expression patterns showed about 2000 genes differentially 
express between GV and MII (Cui, Li et al. 2007). While the differential expression between GV 
and MI oocytes is very minor in all mammalian species, a large amount of modifications to 
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mRNA transcripts occur after MI before entering MII and may be responsible for the widespread 
change in protein composition and abundance that accompany fertilization and transition from 
oocyte to embryo (Assou, Anahory et al. 2006). For example, genes that encode F-box family of 
proteins are overrepresented in oocytes at different stages, are involved in ubiquitin linked 
protein degradation pathway, and have been implicated in this extensive change in protein profile 
along with proteins involved in epigenetic modifications like methylases, demethylases and 
acetylases (Wang, Kou et al. 2010). PADI6, another well-known histone demethylase, is 
involved in ribosome storage and embryonic genome activation and its transcript is present in the 
oocyte after the MI stage (Yurttas, Vitale et al. 2008). 
Human oocytes collected at different stages of maturation and analyzed for gene expression 
levels using microarray and cluster analysis of specific marker and related genes showed that GV 
oocytes have a higher expression of genes involved in protein formation and metabolism, cell 
cycle regulation, electron transport, and production of cytoskeletal elements whereas MII 
oocytes have an overrepresentation of genes involved in DNA replication and repair, cell 
proliferation, lipid and amino acid metabolism, formation of G-protein coupled receptors 
(GPCR) and other signaling molecules (Cui, Li et al. 2007; Gasca, Pellestor et al. 2007). Gene 
networks constructed from mouse oocytes using an IPA database (Ingenuity Pathway Analysis 
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http://www.ingenuity.com/products/pathways_analysis.html) of MII specific genes like Plat, 
Gdp1, Ints9, Gdf9 and Sic23a revealed GO function categories of cellular movement cellular 
assembly and organization, cell cycle regulation, DNA replication, recombination and repair, 
lipid metabolism and apoptosis (Jincho 2008). In addition, genes upregulated in mammalian 
oocytes can be subdivided into various post-prophase I meiotic events, including those 
participating in MPF (Ccnb1, Ccnb2, Cdc2, Cdc25A, Cdc25B, Cdc25C), signaling (Mos, Bmp6, 
Gdf9, Fgf9, Kit, GPR family, Zp1, Zp2, Zp3, Zp4), spindle assembly (Bub1, BubR1, CenpA, 
CenpE, CenpH, Mad2L1), Anaphase-promoting Complex (APC1, APC10, Stag3), transcription 
factors (Sox30, Sox15) and cell cycle regulation (Pttg1, Pttg3, Emi1) (Assou, Anahory et al. 
2006; Cui, Li et al. 2007; Fair, Carter et al. 2007; Wang, Kou et al. 2010). Pttg1 and Pttg3 
encode Securin protein that, along with cohesions, regulate sister chromatid association during 
meiosis II (Assou, Anahory et al. 2006). 
Results similar to the IPA were shown by proteome analysis of mouse oocytes (Wang, Kou et al. 
2010). In general, proteome profiles give a more accurate representation of regulatory networks, 
as non-translation of transcripts and activation of proteins within the cell cannot be assessed by 
transcriptome profiles alone. In the oocyte proteome profile about 2800 GV specific proteins and 
3000 MII specific proteins were identified and a GO annotation analysis showed that GV oocytes 
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specifically contain proteins related to metabolism, oocyte function and maturation (Wang, Kou 
et al. 2010). For example, several protein families involved in molecular transport across oocyte 
and cumulus cell membranes were found to be in abundance in the GV oocytes, such as the 
amino acid transporters of the SLC family, gap junction proteins and adhesion proteins (Wang, 
Kou et al. 2010). Proteins involved in DNA replication and recombination pathway are seen in 
MII oocytes in higher levels than the GV oocytes. MII oocytes in addition to possessing proteins 
for cell cycle regulation, show abundance of specific transcription factors such a SIN3a, TRIM28 
that prevent stem cell differentiation and TCL family of proteins that are involved in 
reprogramming of cells to pluripotency. Both stages of oocytes (GV and MII) show high 
expression of protein families like ARF (ADP ribosylation factor) MATER (Maternal Antigen 
That Embryos Require), Tudor and Fbox family which are required for cell cycle regulation and 
self-renewal. ARF family of proteins is also involved in the asymmetric division of oocytes 
(Wang, Kou et al. 2010). Other over-represented genes in the MII oocytes are part of the MAPK 
pathway and TGFβ pathway, which are involved in oocyte activation, cell differentiation and 
cell proliferation respectively.  For instance, Map2k1 and Pacsin2 are two genes whose products 
are involved in cell signaling pathways and are highly expressed after the GV stage. PACSIN2 
belongs to a family of proteins known to participate in oocyte maturation, fertilization, and early 
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embryonic divisions (Cui, Li et al. 2007). Products of another gene Adam1a are expressed in MII 
and are known to play a role in fertilization. However, ZP proteins, also known to be required for 
fertilization, are formed as early as GV stage oocytes as seen by high expression of Zp1, Zp2, 
and Zp3 genes in GV oocytes indicating a possible role of these proteins in interactions with 
cumulus cells(Cui, Li et al. 2007).  
6.1 Role of cumulus cells in meiotic maturation 
The role of cumulus cells in oocyte maturation and meiotic resumption have been further 
illuminated by gene expression analysis. Genome wide expression analysis in human oocytes 
using oligonucleotide based microarrays reveals significant differences in expression profiles for 
many genes between oocyte and cumulus cells. Some of these genes are known to be oocyte 
specific (Zp1, Zp2, Zp3, Zp4, Gdf9), and others are known to be specific to the meiotic pathway 
within the oocyte (AurkC, Cdc25A, Cdc25B, Cdc25C) (Assou, Anahory et al. 2006). Many genes 
involved in signaling pathways mediated by cumulus cells are over-expressed at all stages of 
development within the oocyte. For instance, genes encoding growth factor receptors (Bmpr2, 
Kit, Erbb4) and GPCRs (Gpr37, Gpr39, Gpr51, Gpr126) are over-expressed in oocytes, 
suggesting the role of their cumulus cell-derived ligands in regulating oocyte maturation (Assou, 
Anahory et al. 2006). 
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Figure 1.3.Genes expressed during different stages of mammalian oocyte development and 
function.  
Genes above the dotted line are expressed in the oocyte and below the dotted line are observed in 
the somatic cell population of the follicle. Oocytes within primary follicles in the ovary have 
upregulation of specific transcription factors required for folliculogenesis (Figla, Nobox), zona 
pellucida formation (Zp1, Zp2, Zp3, Zp4) and post-fertilizational development (Zar1). In the pre-
antral follicles, several oocyte expressed genes like Gdf9, Bmp15 etc are involved in regulation 
of follicle development, proliferation and differentiation of granulosa cells. Within the antral 
follicles several new genes are expressed in preparation for meiotic resumption (Cdk1, Mad2, 
Bub3), cell cycle progression (FMN2 required for polymerization of actin) and GVBD 
(Histone1a required for chromatin remodeling) are expressed in the oocyte. In the cumulus cells 
of the antral follicle, upregulation of genes required for hormone response (LHCGR, FSHR) and 
regulation of follicular atresia (Bcl2) is observed. Ovulation, being similar to an inflammatory 
response, shows an upregulation of mediators of inflammation such as NOS (Nitric oxide 
synthetase) and Cox (cyclo-oxygenases). Genes upregulated in GVBD and MI oocytes are 
required for participating in MPF (Ccnb1, Ccnb2, Cdc2, Cdc25A, Cdc25B, Cdc25C), signaling 
(Mos, Bmp6, Gdf9, Fgf9, Kit, GPR family, Zp1, Zp2, Zp3, Zp4), spindle assembly (Bub1, 
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BubR1, CenpA, CenpE, CenpH, Mad2L1), and Anaphase-promoting Complex (APC1, APC10, 
Stag3). In addition to these, MII oocytes show upregulation of genes that play a role in 
fertilization (Pttg1, Pttg3, Emi1, and Adam1a) and early cleavage divisions (MATER, Pacsin2).  
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 Of the genes that are over expressed in cumulus cells, 24 % are involved in extracellular signals 
and membrane structure indicating their highly supportive role that the cumulus cell play in 
oocyte development (Assou, Anahory et al. 2006).  
Cumulus cells also play a major role in ovulation, and several gene networks spanning the entire 
cumulus-oocyte complex are involved in this process (Kim, Bagchi et al. 2009). Hormonal 
stimulation of the ovary sets in motion a series of events that lead to the expulsion of the now 
viable (and fertilization competent) oocyte from the follicle. Gene profiles from mature follicles 
reveal gene networks comprising of several progesterone-regulated genes like Adamts1, Edn2, 
Pparγ, Il6 and Ptgs2 which code for proteins like proteases, cell adhesion components, 
transcription factors, regulators of vascular activities and inflammation regulators (Kim, Bagchi 
et al. 2009). Each of these networks is involved in the damage and repair events that characterize 
the ovulation process (Kim, Bagchi et al. 2009). 
Transcriptome profiles of human oocytes between MII (unfertilized) stage and the 4-cell embryo 
stage revealed that while a large number of transcripts show an overall decreasing expression, 
there is an increase in the expression of a specific set of genes encoding proteins localized in the 
nucleus and on ribosomes. GO analyses identified these proteins as being required for RNA 
processing and metabolism indicating that they are probably involved in the transition from 
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maternal to zygote genome. The overall reduction in transcripts at this stage could be due to 
degradation of maternal transcripts that accompany this transition (Zhang, Zucchelli et al. 2009). 
The oocyte-derived transcripts at this stage might be responsible for the extensive 
reprogramming of a terminally differentiated cell (the oocyte) to a pluripotent cell (the zygote). 
Study of gene networks involved in this unique process have great value in induced pluripotent 
stem cell (iPSC) research and therapy (Wang, Kou et al. 2010). 
7. Role of the oocyte in ovarian development  
While oocytes are progressing through prophase I of meiosis during fetal life, the somatic cells in 
the ovary surround the germ cell clusters and the whole gonad itself begins to be delineated into 
cortical and medullary regions due to differential gene expression in the cells (Combes A 2010). 
For instance, cortical cells showed a marked increase in Bmp2 expression while medullary cells 
have higher Wnt4, Fst expression. While the exact function of Bmp2 in the cortex cells is not 
known, Follistatin (the protein product of the Fst Gene) is known to be involved in activin-
mediated regulation of ovary function. Rspo1 expression activates the Wnt signaling pathway in 
the ovary which, in turn, suppresses both endothelial cell migration and the formation of testis-
specific vasculature in the ovary (Yao, Matzuk et al. 2004; Combes A 2010). Not surprisingly, 
therefore, GO biological process analysis of Wnt4 shows its involvement in commitment to cell 
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fate in primary germ layers and in branching and patterning of blood vessels (Yao, Matzuk et al. 
2004; Combes A 2010).  
Somatic cells, as expected, influence follicle formation greatly in the postnatal ovary. Foxl2 is 
required for normal follicle formation and is expressed by pregranulosa cells in the gonad 
(E12.5), and then later on the granulosa cells of the early follicles (Combes A 2010). However, 
the oocytes themselves are also important for folliculogenesis, since loss of oogonia at different 
stages of development has been shown to disrupt follicle and ovarian development (Combes A 
2010). In the absence of oogonia, somatic cells can still form clusters, however, they seem 
unable to form follicles and the cell clusters start regressing in a few days (Combes A 2010). 
Two oogonia specific genes, Fig1a and Nobox, have been implicated in the oocyte-driven 
control of folliculogenensis at this stage of development. Loss of oocytes in the meiotic stages of 
development produces a transdifferentiation of pre-granulosa cells of the early follicles to 
Sertoli-like cells indicating that oocytes play an important role in maintaining the female specific 
differentiation pathway at this stage. Wnt4, Rspo1, and Amh expressed in the oocyte have been 
implicated in this part of ovarian development (Acevedo and Smith 2005). Even in much later 
stages of the female reproductive life, loss of oocytes can be detrimental to ovarian function. For 
instance, oocyte loss from preovulatory follicles in the adult ovary causes leutinization of the 
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follicle. Bmp15 and Gdf9 expression in the oocyte have been shown to be responsible in 
preventing this disintegration and for maintaining proper follicle function prior to ovulation 
(Combes A 2010).   
 
8. Conclusions 
Our understanding of cellular processes has been aided greatly by a more complete picture of the 
genetic networks that regulate these events, and the oocyte is no exception.  Indeed, the 
similarities in gene expression profiles between oocytes and somatic cells in terms of their 
proliferative and differentiation programs, and between oocytes during meiosis and the DDR 
program in somatic cells, such comparative genetic profiling will be useful in elucidating 
common mechanisms and in predicting genes that are likely to play important roles in one or 
both pathways.  Indeed, as our ability to perform high throughput sequencing advances, and with 
the emergence of technologies capable of allowing transcriptome profiling of single oocytes, the 
scope and resolution of these gene networks is likely to improve dramatically.  
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CHAPTER 2 
The Mitogen-Activated Protein Kinase (MAPK) pathway and its relation to oocyte biology. 
 
1. Introduction 
The MAPK pathway is a highly conserved signaling cascade that interacts very closely with 
various meiotic events such as meiotic initiation, prophase I, meiotic resumption, meiotic 
transition (MI to MII), maintenance of MII arrest, spindle assembly and checkpoint function (See 
also Chapter 3) (Pfeuty, Bodart et al. 2012). Several pre-meiotic events such as germ cell 
specification, sex differentiation and spermatogonial division also show the involvement of the 
MAPK pathway (Ewen, Jackson et al. 2010; Nagamatsu, Kosaka et al. 2012).  
 
2. MAPKs and meiotic gene networks 
MAPK pathway related gene expression during specific cell functions is a good indicator of the 
role of MAPK within that system. For instance, an expression study of cell cycle genes in male 
meiotic cells of the mouse showed about 550 differentially expressed cell-cycle genes during 
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various stages of spermatogenesis. Of these about 100 or more were known to be components of 
cell-cycle regulating pathways such as those for DNA repair, ubiquitination, cell signaling etc 
(Roy Choudhury, Small et al. 2010). Several of these genes have products that are known 
components of the MAPK pathway [MAPK1, MOS, MAPK4, MAPK6, MAPK7, MAPK13] and 
several others that are closely associated in the signaling cascade [JUN, RAF, RAS]. Several 
other genes that are regulated during meiosis have products that are known or putative interactors 
with components of the MAPK pathway [MAD2, MAD2L1, BUB1, BUB1B, BUB3, NEK2, 
WEE1, MPS1, CREB]. Of these, MAD and BUB protein complexes are known to be involved in 
spindle assembly checkpoint function for accurate assembly and maintenance of the bipolar 
spindle (Steuerwald, Cohen et al. 2001). NEK2 and CREB are involved in chromatin 
condensation for both spindle function as well as transcriptional regulation (Di Agostino, Rossi 
et al. 2002; Sonn, Oh et al. 2011). 
2.1 Gene networks showing involvement of MAPKs in spindle configuration and function 
Two oocyte specific proteins, OBOX4, a homeobox family member is known to be involved in 
meiotic development of mouse oocytes (Lee, Kim et al. 2011). OBOX (Oocyte specific 
Homeobox) is a family known to be expressed only in mammalian oocytes during 
folliculogenesis and meiotic resumption (Rajkovic, Yan et al. 2002). Of this group, OBOX4 is 
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thought to play a role in spindle configuration and chromosome segregation during MI to MII 
transition (Lee, Kim et al. 2010). An RNAi induced reduction in Obox4 transcripts resulted in an 
MI arrest and differential expression of approximately 420 genes. KEGG groupings of these 
differentially expressed genes showed several pathways involved in metabolism, cell cycle 
regulation etc. The MAPK pathway was in the top 15 of the list generated by the KEGG analysis 
(Lee, Kim et al. 2011). Specifically, among the Obox4 knockdown induced down-regulated gene 
clusters, were several genes whose products are components of the ERK/MAPK pathway 
[MEK2, MEK1, ERK2, ERK1] and genes whose products are involved in the cytoskeletal 
dynamics of oocyte division [Cdc42, Rac, F- Actin] (Zheng, Baibakov et al. 2013).  
 
3. Conclusions 
Stage-specific expression of gene networks regulate meiosis and germ-cell development. These 
gene networks include components of cell signaling cascades such as the MAPK pathway 
indicating their role in the regulation of meiotic events. Much of what is known about the MAPK 
signaling cascade is in relation to the transcriptional control brought about by the cascade in 
response to mitogenic signals. However, in addition to this, MAPKs specifically ERKs, are 
thought to be involved in cellular division, cytoskeletal reorganization and segregation of genetic 
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material. In investigating the role of ERKs and other regulators in cytoskeletal organization, 
chromosome segregation and ploidy, the oocyte has proved to be an excellent model.  
So far pharmacological approaches have been used to study the action of ERKs in oocytes in 
vitro using inhibitors of the ERK pathway. However, these are not truly reflective of the 
physiological environment of the ovary. Also, while deletion of Erk1 seems to have no effect on 
the viability of the mice, Erk2 deletion causes embryonic lethality. Therefore it is impossible to 
study the effect of total ERK ablation in the oocyte and adult ovary. Hence, in order to better 
understand the mechanism of action of ERKs on oocyte division, we have generated an Erk2 
conditional deletion system driven by an oocyte specific Cre on an Erk1 null background. This 
system proves to be an excellent model to study the roles of MAPK proteins ERK1 and ERK2 
and their downstream signaling activity in meiotic cell cycle, oocyte division, chromosome 
segregation and early embryo development.  
MAPKs are integral to meiotic regulation. Therefore, I hypothesize that deregulation of the 
MAPK pathway in oocytes will produce drastic changes in the spindle dynamics and in 
chromosome segregation. The above mentioned mouse model will be an excellent resource 
for delineating the exact mechanisms that bring about any such defects. 
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CHAPTER 3 
Disruption of ERK activity in mouse oocytes results in infertility due to failed early 
embryonic development. 
This chapter has been written as a manuscript for publication and is being submitted to 
scientific journals for peer review. Sections marked with * are not included in the original 
manuscript. 
 
1. Abstract 
The extracellular signal-regulated kinases, ERK1 and ERK2, are the major mitogen-activated 
protein kinases (MAPK) that respond to a variety of growth factors, hormones, and cytokines.  In 
mammalian germ cells, ERK1 and ERK2 regulate G2/M transition, while phosphorylation-
induced activation of ERKs in oocytes and granulosa (Fan et al., 2009) accompanies post-
pubertal resumption of meiosis. Here we utilize a conditional approach to delete Erk1 and Erk2 
specifically in mouse oocytes after birth, prior to germinal vesicle breakdown.  Double mutant 
females are infertile, with gross chromosome misalignment on metaphase spindles in oocytes, 
and severe early embryonic loss. These changes coincide with a loss of ERK-dependent MSK1 
phosphorylation and disruption of histone H3 phosphorylation on metaphase II spindles. In 
contrast, a major downstream target of ERK1 and ERK2 in somatic cells, RSK1, is unaffected by 
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the loss of ERK signaling in the oocyte.  Our results demonstrate that ERK activity specifically 
within the oocyte is essential for meiotic resumption and for normal pre-implantation 
development. 
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2. Introduction 
The MAP kinases are serine-threonine kinases that are part of a cascade that transduce a variety 
of extracellular signals (Raman, Chen et al. 2007), into a wide range of cellular effects including  
proliferation, apoptosis, cell movement and differentiation (Cargnello and Roux 2011). ERK1 
and ERK2 (also known as MAPK3 and MAPK1, respectively) share approximately 83% 
similarity at the amino acid level, and both are expressed in a variety of tissues including those of 
the reproductive tract (Kang, Tai et al. 2000).  In the ovary, pituitary gonadotropins activate the 
ERK1/ERK2 pathway in the granulosa cells mainly via the activation of epidermal growth factor 
receptor, leading to activation of the cRaf kinase (MAPKKK), and downstream activation of 
ERK1 and ERK2 (Cameron, Foster et al. 1996).  This ERK-driven cascade is essential for 
ovulation, cumulus-oocyte complex expansion, oocyte maturation and follicle leutinization (Su, 
Wigglesworth et al. 2002; Richards and Pangas 2010).  Studies in mammals and other vertebrate 
systems indicate that the ERK pathway also functions within the oocyte itself, participating in 
several post-prophase I events, including spindle formation (Yu, Xiong et al. 2007), maintaining 
spindle stability (Petrunewich, Trimarchi et al. 2009), the spindle assembly checkpoint (Cross 
and Smythe 1998; Schwab, Roberts et al. 2001), polar body extrusion (Choi, Fukasawa et al. 
1996), metaphase II arrest (Phillips, Petrunewich et al. 2002) and fertilization (Fan and Sun 
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2004; Li, Lian et al. 2011).  All of these studies have utilized pharmacological approaches 
involving the application of inhibitors such as U0126, which inhibits MAPK-ERK kinase or 
MEK, the upstream activator of ERKs.  However, the granulosa cell-specific function for ERKs 
in oocyte maturation precludes the use of such inhibitors for understanding oocyte-intrinsic ERK 
function during meiotic resumption. Moreover, since processes such as oocyte development, 
ovulation and fertilization are best observed in a physiological milieu, the use of these 
pharmacological inhibitors on isolated oocytes in vitro is inadequate.  Therefore, in order to 
understand the oocyte-intrinsic role of ERK1 and ERK2 during post-prophase I meiotic 
resumption and fertilization changes, we employed a very specific LoxP-Cre recombinase 
mediated conditional deletion of Erk2 on an Erk1 null background. 
 
3. Materials and Methods 
 
3.1 Generation of the Erk2 fl/fl Erk1-/- mouse  
 Wildtype control mice and Zp3-Cre mice were obtained from Jackson Laboratories. The 
Erk1 knockout strain (Erk2fl/flErk1-/-) have been reported in previous study (Bliss, Miller et al. 
2009). Mice with ERK 1/2 double deletion in oocytes were generated by crossing Zp3-cre line 
	  	  
63	  
with the Erk2fl/fl Erk1-/- line. All the mice used in this study are on a C57BL/6 background. 
Animals were housed according to the Cornell University Institutional Animal Care and Use 
Committee regulations. For breeding studies 6-8 week old female mice were housed two at a 
time with a wildtype male of proven fertility and checked for vaginal plugs daily. On observation 
of a plug, the females were housed individually for duration of 21 days after which the litter size 
was noted. 
 
3.2 Genotyping 
 Tail snips were used as a source of genomic DNA. PCR genotyping strategies for Erk1 
and Erk2 were performed as described previously (Bliss, Miller et al. 2009). Cre PCR for 
confirming the recombination at Erk2fl/fl employed the following primers-                                                   
Forward: GTCGATGCAACGAGTGATGAGGTTCG and                                                 
Reverse: CCAGGCTAAGTGCCTTCTCTACACCTGC. 
 
3.3 Oocyte retrieval and culture 
For assessment of GVBD, MI and MII spindle structures, oocytes were collected from ovaries of 
21-day-old mice by follicle puncture with a 26.5 gauge needle in M2 medium containing 
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hyaluronidase (MR 051F, EMD Millipore, Billerica, MA). For superovulation, 4 week old 
females were injected with PMSG (5 IU, i/p) followed by hCG (5IU, i/p), and oocytes were 
collected from oviducts the following morning. The oocytes were then transferred to M2 medium 
without hyaluronidase (MR 015D, EMD Millipore, Billerica, MA) and finally to KSOM medium 
(MR 020P, EMD Millipore, Billerica, MA) under oil in a 35 mm culture dish. The oocytes were 
then incubated in conditions of 5% O2 and 5% CO2 at 37C for specific time periods: GVBD 
(3hrs), MI (~8hrs) and MII (16hrs). MII stage was confirmed by the presence of a polar body.  
 
3.4 Embryo collection and culture 
For assessment of early embryo development, females were housed with proven wildtype males 
and checked for vaginal plugs daily. Upon observation of a plug the female was euthanized and 
fertilized oocytes were collected from the oviduct in M2 medium with hyaluronidase. 
Fertilization was confirmed by the presence of two polar bodies. About 10 fertilized oocytes 
were cultured in a 26 µl droplet of KSOM under oil under conditions of 5% O2 and 5% CO2 at 
37C with change of media every 24 hours for 6.5 days.  
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3.5 Assessment of reproductive competence  
Female mice were housed with proven wild type males for 6 days and were checked for 
copulation plugs daily. Pregnancy was assessed by regular monitoring of body weight and 
delivery of litters 20-21 days following copulation.  
 
3.6 Vaginal cytology 
Vaginal cytological examination was performed to assess the estrous cycles of the Erk1 SKO and 
Erk1/2 DKO animals. Briefly, cytological smears were made from vaginal swabs collected from 
mice at the same time each day. Slides were allowed to air dry and stained with Wright-Giemsa 
reagent (VWG-128, Volu-Sol, Sal Lake City, UT) and observed under the light microscope. 
Stages of the estrous cycle were differentiated based on the morphology and abundance of 
epithelial cells and leucocytes.  
 
3.7 Detection of implantation 
Mice were anesthetized 5.5 days after detection of vaginal plug with 0.5 ml of Avertin (T48402, 
Sigma-Aldrich, St Louis, MO) and the jugular artery was exposed by resecting skin. 0.1 ml of 
1% Pontamine Blue solution in 0.9% saline (Product 34139, BDH Chemicals, Poole, England) 
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was very slowly injected into the jugular artery. The animals were then euthanized and the uteri 
were dissected.  
 
3.8 Histology  
For immunohistochemical labeling, ovaries were dissected out from 4-6 week old female mice. 
Tissues were fixed in 4% freshly prepared paraformaldehyde, embedded in paraffin and 
sectioned at 4 µm onto poly-L Lysine coated glass slides. Quality of sections was determined by 
hematoxylin and eosin staining as per standard procedure. 
  
3.9 Immunohistochemistry 
For immunostaining sections were deparaffinized, rehydrated and treated with 3% hydrogen 
peroxide. Antigen retrieval was done by boiling in 10mM sodium citrate buffer, pH 6.0. Sections 
were blocked in 1X TBST/ 5% NGS and incubated with rabbit anti-ERK1/2 antibody (4695, Cell 
Signaling Technology, Boston, MA) at 1:100 overnight at 4C. HRP conjugated goat anti-rabbit 
(31460, ThermoScientific, Rockford, IL) was used as secondary antibody. Color development 
was by Nova-Red (SK 4805, Vector labs, Burlingame, CA). 
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3.10 Immunofluorescent labeling 
Immunofluorescent labeling of oocytes was performed as described previously (Mullen and 
Critser 2004). Briefly, oocytes were fixed in buffer containing 2% PFA, blocked for 1 hour at 
room temperature and incubated in primary antibody overnight at 4C. Oocytes were then 
washed, incubated in secondary antibody at room temperature for 1 hour and mounted in 
antifade containing DAPI. The cover glass was fixed over the slide using a 1:1 mixture of 
paraffin and petroleum jelly. Antibodies used were mouse anti-beta tubulin (T8328, Sigma-
Aldrich, St Louis, MO), Rabbit anti-ERK 1/2 (4695, Cell Signaling Technology, Boston, MA), 
mouse anti-Gamma tubulin (ab27074, Abcam, Cambridge, MA), Rabbit anti-MSK1 (3489, Cell 
Signaling Technology, Boston, MA), Rabbit anti-pMSK1 Thr581(9595, Cell Signaling 
Technology, Boston, MA) and Rabbit anti-phospho histone H3 Ser10 (6570, EMD Millipore, 
Billerica, MA). 
 
3.11 Western Blotting 
For protein detection with western blot, oocytes were pooled from 4-6 week old superovulated 
female mice and lysed in 2X Laemelli buffer. Samples were immediately boiled at 95C and 
cooled on ice. Proteins were separated in an SDS-PAGE electrophoretic system and transferred 
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onto a Immuno-Blot PVDF membrane (162-0177, BioRad, Hercules, CA). Membranes were 
probed with mouse anti-beta tubulin (T8328, Sigma-Aldrich, St Louis, MO), Rabbit anti-ERK 
1/2 (4695, Cell Signaling Technology, Boston, MA), mouse anti-Gamma tubulin (ab27074, 
Abcam, Cambridge, MA), Rabbit anti-MSK1 (3489, Cell Signaling Technology, Boston, MA), 
Rabbit anti-pMSK1 Thr581(9595, Cell Signaling Technology, Boston, MA) and Rabbit anti-
phospho histone H3 Ser10 (6570, EMD Millipore, Billerica, MA) according to manufacturer 
instructions.  
 
3.12 Statistical analysis 
Statistical analysis of experiments was done by student t-test and analysis of variance as 
applicable. All statistical tests were performed using Prism 4.0 software (Graphpad). 
 
3.13 Microscope image acquisition 
Acquisition and processing of images was performed by microscope (Imager Z1; Carl Zeiss, 
Inc.) under a 10x eye-piece and 40× 0.5 NA ECPlan Neofluar air immersion (Carl Zeiss, Inc.) or 
63× 1.4 NA Plan Apochromat oil immersion (Carl Zeiss, Inc.) magnifying objective at room 
temperature, cooled charged-coupled device camera (AxioCam MRm; Carl Zeiss, Inc.) and 
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AxioVision software (version 4.7.2; Carl Zeiss, Inc.). Images were analyzed using ImageJ 
program (ImageJ64.app, NIH).  
 
4. Results and Discussion 
In order to understand the oocyte-intrinsic role of ERK1 and ERK2 during post-prophase I 
meiotic resumption and following fertilization, we utilized oocyte-specific Cre recombinase 
mediated conditional deletion of Erk2 on a background that is null for Erk1 (Bliss, Miller et al. 
2009).  Ubiquitous Erk2 deletion in the mouse results in embryonic lethality (Hatano, Mori et al. 
2003; Saba-El-Leil, Vella et al. 2003), and thus we used a floxed allele of Erk2 (Erk2 fl/fl) 
together with a null allele of Erk1 (Erk1-/-).  Erk1-/- mice are viable and fertile (Pages, Guerin et 
al. 1999), while Erk2 deletion was achieved through the use of a Zp3-Cre transgenic mouse in 
which Cre is expressed exclusively in the oocyte from postpartum Day1, prior to completion of 
the first meiotic division (Lewandoski, Wassarman et al. 1997).  The resulting Erk1-/-.Erk2fl/fl 
Cre+ mice, hereafter referred to as the Erk1/Erk2 double knockout or Erk1/Erk2 DKO, were 
compared with Erk1-/-.Erk2fl/fl.Cre- (also known as Erk1-/- single nulls, Erk1 SKO) littermates and 
wildtype C57 controls.  
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4.1 Total ERK proteins are absent in the DKO oocytes 
ERK1 and ERK2 proteins localize to both the granulosa cell layers and the oocyte in the adult 
mouse ovary, the levels in the latter increasing upon follicular hormonal stimulation. Staining 
with anti-ERK antibodies on the Erk1/Erk2 DKO mouse ovary sections confirmed the loss of 
ERK protein specifically in oocytes of the DKO mice, with normal ERK protein localization in 
the surrounding granulosa cell layers (Fig 1a). In Erk1 SKO, however, ERK staining was still 
observed within the oocytes at all stages of development. When looking specifically at ERK 
localization within the oocyte, we observe ERK immunoreactivity on the metaphase I (MI) and 
metaphase II (MII) spindles in oocytes from wildtype control females (Fig 1B). Residual ERK 
immunoreactivity was observed in oocytes from Erk1 SKO, indicating the persistence of ERK2 
in these mice, while the total absence of ERK from Erk1/Erk2 DKO mouse oocytes spindles 
confirmed the more extensive absence of both ERK1 and ERK2 (Fig 1).  Protein detection by 
western blot on oocyte lysates corroborates the absence of both total ERK and phospho-ERK in 
the Erk1/Erk2 DKO oocytes (Fig 1C).  
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Figure 3.1. Localization of total ERK protein in mouse oocytes.  
(A) Total ERK immunoreactivity (red staining) was assessed in sections of adult ovary from 
wildtype (left panels), Erk1 SKP (middle panels) and Erk1/2 DKO females.  Loss of the ERK 
was observed in Erk1/2 DKO ovary sections, confirming the deletion of both genes in these 
mice. Scale bar 100 µm.  (B) Localization of total ERK protein on meiotic spindles of MII 
arrested oocytes from wildtype control (Panel i), Erk1SKO (Panel ii) and ERK 1/2 DKO (Panel 
iii) animals with antibodies against ERK 1/2 (Texas-red conjugated) and b-tubulin (FITC 
conjugated).   Panels show, from left to right, merged images from both flurochromes, total ERK 
1/2 and chromatin. Total ERK signal is absent in the Erk1/2 DKO oocytes. Scale bar 10 µm.  (C) 
Absence of total ERK protein in oocyte lysates confirmed by western blot. Wildtype and Erk1/2 
DKO oocyte pools of 100 oocytes each in adjacent lanes, probed by Total ERK antibody and 
phospho-ERK antibody showing bands (~ 45kDa) in the wildtype lane and absence of bands in 
the Erk1/2 DKO lanes. Tubulin used as loading control (~50kDa).  
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4.2 Erk1/2 DKO animals have regular estrus cycles but are infertile 
Reproductive performance and breeding efficiency were compared between wildtype females 
and those lacking either one Erk gene (Erk1 SKO) or two (Erk1/Erk2 DKO).  Erk1/Erk2 DKO 
mice do not produce any offspring, while Erk1 SKO females had litter sizes comparable to 
wildtype controls (Fig 2A). However, Erk1/Erk2 DKO females undergo normal estrous cycles 
(Fig S1A,B), mate with normal regularity (Fig S1C), and reach puberty at an equivalent age to 
that of Erk1 SKO and wildtype littermate females (Fig 2B, Fig S1B).  Thus, despite an 
apparently normal endocrine milieu in both Erk1/Erk2 DKO and Erk1 SKO adult females, the 
DKO mice fail to produce live offspring. 
4.3 Erk1/2 DKO animals fail to show implantation of embryos 
To narrow down the timing of pregnancy failure in the Erk1/Erk2 DKO females, we assessed 
implantation rates in the DKO strain using the extravasation of Pontamine blue.  This 
macromolecular dye localizes to sites of high vascular permeability (Boshier 1970), thus 
allowing for the earliest possible detection of implantation within hours of initial implantation.  
Intravenous injection of Pontamine blue at day 4.5 after plug formation into Erk1 SKO females 
showed normal appearance and frequency of blue bands across both uterine horns, each band 
corresponding to a single implanting embryo (Fig. 2C) at frequencies that were similar to that of 
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wildtype females.  By contrast, Pontamine blue injection into Erk1/Erk2 DKO females showed a 
complete absence of the blue banding across the uterus, indicative of no implantation-stage 
embryos or failed implantation at this stage. 
4.4 Erk1/2 DKO animals show normal folliculogenesis and ovulation rates 
To differentiate between failed implantation, failed oogenesis/ovulation, and failed fertilization 
in Erk1/Erk2 DKO females, we undertook a sequential analysis of female ovarian histology and 
folliculogenesis.  Comparison of the ovarian histology between Erk1 SKO, Erk1/Erk2 DKO, and 
wildtype females revealed no gross morphological differences (Fig 2D). All stages of oocyte 
development were noted in ovarian sections from the DKO females. The appearance and 
abundance of ovarian follicles also appeared to be similar in mice of all three genotypes. The 
presence of numerous corpora lutea (CL) indicated that ovulation occurs in the single and double 
knockout mice.  Indeed, treatment of Erk1 SKO, Erk1/Erk2 DKO, and wildtype females with 
exogenous gonadotropins to induce ovarian hyperstimulation resulted in the ovulation of similar 
numbers of oocytes in mice from all three genotypes (Fig 2E).  Thus, folliculogenesis, ovulation, 
and post-ovulatory CL formation are not dependent on ERK activity within the oocyte. 
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Figure 3.2. Evaluation of reproductive phenotypes of the Erk1/2 DKO females.   
(A) Data from breeding studies conducted on age-matched wildtype, Erk1 SKO and Erk1/2 DKO 
females, mated to fertile wildtype males. Average litter size expressed as mean + standard error 
of the mean (SEM). (B) Results from vaginal cytology performed at 24 hour intervals in Erk1 
SKO (n=17) and Erk1/2 DKO (n=23) animals are shown as mean + SEM of the number of 
estrous cycles reached in 26 days. P= 0.85.  (C) Implantation rates were assessed in Erk1 SKO 
and Erk1/2 DKO animals at day 5.5 post-coitus by intravenous Pontamine Sky blue dye 
injection.  (D) Histological assessment of ovaries from wildtype control, Erk1 SKO and Erk1/2 
DKO was done on H&E stained sections. Scale bars for left hand three panels, 200 µm. Scale 
bars for middle and right hand panels (six panels in total), 50 µm.  (E) Ovulation rates were 
assessed by superovulation with exogenous gonadotropin administration. Numbers indicate the 
number of ova collected per group.  
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4.5 Erk1/2 DKO females show progressive embryo death following fertilization 
Since ovulation was observed to be normal in the Erk1/Erk2 DKO females, we next looked into 
development following fertilization in the Erk1/Erk2 DKO oocytes.  Females were mated with 
wildtype males, to produce heterozygous zygotes, which were then cultured in vitro. When 
cultured, fertilized oocytes from Erk1/Erk2 DKO females showed significant death rate at each 
stage of development (Fig 3A,B) with a very small percentage (3%) of embryos reaching the 
blastocyst stage in the absence of both ERKs. Erk1 SKO females also showed progressive loss of 
fertilized oocytes, though not to the same extent as that seen in Erk1/Erk2 DKO females. This 
indicates that the functions of ERK1 and ERK2 in the oocyte may not be redundant. The gross 
morphology of one-cell and two-cell embryos from the Erk1/Erk2 DKO mice did not differ from 
the embryos of Erk1 SKO or wildtype females (Fig 3A). Clearly, the presence of paternally 
derived ERKs in one-cell and two-cell embryos is not sufficient to prevent the developmental 
defects that result in progressive loss of pre-implantation embryos, indicating strongly that the 
cause of the embryo loss lies with the loss of ERKs in the oocyte.  
4.6 Erk1/2 DKO oocytes show normal rates of meiotic resumption in culture 
Meiotic resumption is initially marked by germinal vesicle breakdown (GVBD) in the oocyte, 
and is dependent on MAPK activity in surrounding granulosa cells (Abrieu, Doree et al. 2001; 
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Liang, Su et al. 2007; Fan, Liu et al. 2009). High levels of MAPK cause closure of gap junctions 
between granulosa cells and the oocyte by the phosphorylation of gap-junction protein Connexin 
43 (Norris, Freudzon et al. 2008; Norris, Ratzan et al. 2009; Sun, Miao et al. 2009), thereby 
disrupting the supply of cAMP to the oocyte (Liang, Su et al. 2007; Norris, Ratzan et al. 2009; 
Tripathi, Kumar et al. 2010). This net reduction in cAMP causes inactivation of protein kinase A 
leading to the activation of Cyclin B-CDK1 complex (MPF) by dephosphorylation of CDK1 
(Oh, Han et al. 2010) and subsequently, GVBD. Since Erk2 expression is not disrupted in the 
granulosa cells of the Erk1/Erk2 DKO mutant females, we predicted that meiotic resumption, as 
measured by GVBD, would not be affected in the double mutants. As expected, resumption of 
meiosis in oocytes collected from large antral follicles in of Erk1 SKO and Erk 1/Erk2 DKO 
mutants was similar to that seen in wildtype controls (Fig S2A), indicating that oocyte ERK 
activity is not required for meiotic resumption. These observations contradict earlier studies in 
which pharmacological activation of the intra-oocyte MAPK pathway results in activation of 
MPF, in turn leading to GVBD (Fissore, He et al. 1996; Liang, Su et al. 2007). 
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Figure 3.3. Evaluation of early embryonic development in vitro using oocytes harvested 
from wildtype, Erk1 SKO, and Erk1/2 DKO females.  (A) Images showing each of the four 
stages represented in the graph (B) from Erk1 SKO and Erk1/2 DKO animals. Scale bar, 100 
µm. (B) Quantitation of oocyte development:  Fertilized oocytes were collected from the 
oviducts of wildtype controls (n=8), Erk1 SKO (n=8) and Erk1/2 DKO (n=9) animals mated with 
wildtype males and cultured till blastocyst stage. Percentages indicated in each stage are with 
respect to total fertilized oocytes in the respective group. Values for each group were compared 
by One-way ANOVA, P<0.01. 
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4.7 Erk1/2 DKO oocytes demonstrate severe defects in spindle assembly, chromosome 
segregation and polar body formation 
Following GVBD, the oocyte proceeds into the first meiotic division and finally to meiosis II 
(metaphase stages of these being referred to as MI and MII respectively). Absence of ERKs, as 
seen in Mos-/- oocytes and pharmacological disruption of MEK 1 and 2, results in abnormal 
spindle assembly at MI (Araki, Naito et al. 1996; Choi, Fukasawa et al. 1996; Fan and Sun 2004) 
and MII (Yu, Xiong et al. 2007). MAPKs play an important role in the formation and 
maintenance of a bipolar spindle in both MI and MII (Verlhac, de Pennart et al. 1993; Liang, Su 
et al. 2007; Yu, Xiong et al. 2007), but this requirement has only been studied thus far by 
pharmacological methods. Using our mouse models for genetic loss of Erk1 and Erk2, we 
observed that the MII spindle structure of the Erk1/Erk2 DKO oocytes was grossly abnormal 
compared to that seen in oocytes from wildtype (Fig 4A, panel a) and Erk1 SKO females (Fig 
4A, panel b). Chromosome placement at the metaphase plate in the Erk1/Erk2 DKO females 
showed significant rates of misalignment, while the spindle itself had a less compact appearance 
in the Erk1/Erk2 DKO oocytes, characterized by a more diffuse staining pattern of anti β-tubulin 
antibody and a less compact appearance of microtubules on the spindles (Fig 4A, panels c(i)-
c(iii)). Quantitation of spindle abnormalities showed a significant increase in the percentage of 
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oocytes exhibiting chromosome misalignment as compared to wildtype and Erk1 SKO oocytes 
(Fig 4B).  
MAPKs have also been shown to associate with the microtubule-organizing center (MTOC) at 
spindle poles during meiosis (Verlhac, de Pennart et al. 1993). Further analysis of the spindle 
structure revealed an abnormality in the spindle MTOC at the spindle poles based on gamma-
tubulin immunostaining patterns. MTOCs of wildtype oocytes had the normal ring shape (Ou, Li 
et al. 2010), while that of the Erk1/Erk2 DKO oocytes appeared to be severely fragmented (Fig 
4C), indicating that spindle defects may be caused by abnormal nucleation of microtubules. 
These phenotypes, together with the association of ERKs with γ-tubulin, demonstrate that the 
ERKs play an important role in microtubule nucleation, organization and dynamics(Verlhac, de 
Pennart et al. 1993; Fan and Sun 2004). 
ERKs are thought to regulate spindle migration to the cortex via their action on microfilament 
network in oocytes (Sun, Lai et al. 2001), thereby ensuring the asymmetric division that is 
essential for preserving the accumulated stores of proteins within the oocytes (Chaigne, Verlhac 
et al. 2012). Pharmacological inhibition at any step of the ERK pathway, therefore, leads to 
improper migration of the spindle, extrusion of bigger polar bodies and hence, a loss of resources 
for the developing embryo (Verlhac, Lefebvre et al. 2000; Chaigne, Verlhac et al. 2012). The  
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Figure 3.4. Morphology and quantitation of oocyte defects in Erk1/2 DKO females. (A) MII 
arrested oocytes from wildtype control (n= 20 ), Erk1 SKO (n= 20) and Erk1/2 DKO (n= 18) 
animals were immunolabelled with antibody against b tubulin (Texas- Red conjugated in panel 
A, FITC conjugated in panels B and C) and with DAPI to visualize chromatin. Arrows indicate 
chromosomes that are misaligned on the spindle. Scale bar, 10 µm. (B) Polar body size by 
measurement of diameter shown as a percentage of total oocyte diameter in wildtype (n=10) and 
Erk1/2 DKO (n=10) oocytes. Bars represent mean + standard error of the mean (SEM). 
Statistical comparisons were performed using Student’s unpaired T tests, P<0.0001.  (C) 
Comparison of spindle MTOC structure by gamma tubulin immunolabeling of Erk1 SKO (n= 5) 
and Erk1/2 DKO (n= 7). Arrow indicates MTOC at the spindle pole. (D) Percentages of 
misaligned chromosomes on MII spindles were calculated in oocytes from wildtype controls (n= 
72), Erk1 SKO (n= 67) and Erk1/2 DKO (n= 73). Bars represent mean + SEM. Statistical 
comparisons were performed using one-way ANOVA, followed by Tukey’s multiple comparison 
test,  p= 0.048. (E) Pole-to-pole spindle lengths were measured in spindles from MII arrested 
oocytes from wildtype controls (n= 20), Erk1 SKO (n= 20) and Erk1/2 DKO (n= 20). Bars 
represent mean + SEM. Statistical comparisons were performed using one-way ANOVA, 
followed by Tukey’s multiple comparison test, p= 0.017. 
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polar body size with respect to the size of the oocyte was observed to be significantly higher in 
the Erk1/Erk2 DKO females (Fig 4D). Pole-to-pole spindle length was significantly higher in 
oocytes from Erk1/Erk2 DKO females (Fig 4E). However, the width of the MII spindle across 
the midplate, and the distance of the spindle from the cortex did not show any significant 
differences between the genotypes (Fig S3A,B).  
4.8 Erk1/2 DKO oocytes exhibit deficiency of phosphorylation of kinase downstream of 
ERK1 and ERK2. 
To elucidate the downstream signaling events for ERK1 and ERK2 in the oocyte, we examined 
the phosphorylation status of classic ERK targets such as Ribosomal S6 Kinase (RSK) and 
Mitogen and Stress activated protein Kinase (MSK1).  Of these MSK1 showed differential 
phosphorylation status in the Erk1/Erk2 DKO oocytes (Fig 5A,B), while RSK1/2/3, previously 
thought to be the canonical downstream targets of the MAPK pathway during meiotic 
maturation, showed no such change (data not shown). Whereas oocytes from wildtype females 
show an accumulation of phospho-MSK1 (p-MSK1) on the MII spindle, Erk1/Erk2 DKO 
oocytes show a complete absence of p-MSK1 (Fig 5A). Absence of p-MSK1 was further 
demonstrated in the Erk1/Erk2 DKO oocytes by western blotting (Fig 5B) while total MSK1 
levels were similar in both the Erk1/Erk2 DKO oocytes and the control (Fig S4). So far one 
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study on mouse oocytes the possible involvement of MSK1 in oocyte division. In that, the 
authors shown a similar localization of pMSK1 on the metaphase II spindle and an absence of 
MSK1 phosphorylation in the presence of MEK inhibitor U0126, confirming the 
phosphorylation of MSK1 by the MAPK pathway (Miyagaki, Kanemori et al. 2011). Moreover, 
pharmacological inhibition of MSK1 produced absence of a bipolar MII spindle and failure to 
maintain sister chromatid alignment at the metaphase plate (Miyagaki, Kanemori et al. 2011). 
Pharmacological inhibition of MSK1 was involved in spontaneous release from MII arrest 
possibly due to defective phosphorylation of Emi2 (Miyagaki, Kanemori et al. 2011). However, 
because we did not observe a significant increase in spontaneous release from MII arrest (Fig 
S5), we investigated other possible pathways of MSK1 activity in oocytes.  
4.9 Erk1/2 DKO oocytes demonstrate reduction in the phosphorylation status of chromatin 
condensation factor Histone H3. 
The actual biological pathway of MSK1 is not completely understood as Msk1-/- mice are viable 
and fertile (Drobic, Espino et al. 2004). In mouse fibroblasts, the ERK signaling pathway has 
been shown to elevate activated (phosphorylated) MSK1 levels, resulting in the elevation of 
steady-state levels of Serine10 phosphorylated Histone-3 (H3S10), a target of MSK1(Drobic, 
Espino et al. 2004). Phospho-histone H3 plays a central role in chromosome condensation and 
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spindle assembly during mitosis in Drosophila (Giet and Glover 2001) making it a strong 
candidate in the ERK-mediated control of oocyte division and spindle function, as demonstrated 
by our current data. Moreover, morpholino knockdown of histone H3.3, a variant of histone H3, 
results in mis-segregation of chromosomes, aneuploidy and developmental arrest of early mouse 
embryos (Lin, Conti et al. 2013). Analysis of histone H3 function in our Erk deficient oocytes 
shows a significant reduction in the levels of phosphorylated H3 at Serine 10 in the Erk1/Erk2 
DKO oocytes (Fig 5C). Immunohistochemical staining of oocytes demonstrated the localization 
of p-H3S10 on the chromosomes of MII spindles; however, this localization was significantly 
reduced in the Erk1/Erk2 DKO oocytes (Fig 5D,E).  This suggests that MSK1 phosphorylation 
by ERKs may play a key role in maintaining spindle integrity via its action on chromatin 
condensation factors such as histone H3.  
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Figure 3.5. Identification of downstream signaling targets of ERK1/2 in mouse oocytes. (A)  
MII arrested oocytes from wildtype control (n= 15 ) and Erk1/2 DKO (n= 17) animals were 
immunolabelled with antibody against b tubulin (Texas- Red conjugated), phospho-MSK1 (FITC 
conjugated) and with DAPI to visualize chromatin. Arrows indicate co-localization of pMSK1 
on the spindle. Scale bar, 10 µm.  (B) Absence of phospho-MSK1 in oocyte lysates confirmed by 
western blot. Wildtype and Erk1/2 DKO oocyte pools of 80 oocytes each in adjacent lanes, 
probed by phospho-MSK1 antibody showing band (~ 90kDa) in the wildtype lane and absence of 
band in the Erk1/2 DKO lanes. Tubulin used as loading control (~50kDa).  (C) Analysis of 
phospho-Histone H3 in oocyte lysates confirmed by western blot. Wildtype and Erk1/2 DKO 
oocyte pools of 80 oocytes each in adjacent lanes, probed by phospho-H3S10 antibody showing 
band (~ 17kDa) in the wildtype lane and absence of band in the Erk1/2 DKO lanes. Tubulin used 
as loading control (~50kDa). (D) MII arrested oocytes from wildtype control (n= 10) and Erk1/2 
DKO (n= 10) animals were immunolabelled with antibody against phospho-H3S10 (FITC 
conjugated) and with DAPI to visualize chromatin. Fluorescence intensity measured with ImageJ 
(E), and quantitated as Corrected Total Cell Fluorescence (CTCF) calculated in oocytes from 
wildtype controls (n= 10) and Erk1/2 DKO (n= 10). Bars represent mean + SEM. p= 0.0009 
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5. Conclusions 
Our work on the Erk1/Erk2 DKO mice demonstrates a specific requirement for ERK1 and ERK2 
for proper function of, and chromosome placement on, the MI and MII spindles. Taken together, 
our data demonstrate an essential role for ERK signaling in meiotic resumption and progression 
through fertilization in the mouse. Specifically, combined loss of ERK1 and ERK2 drastically 
alters spindle function and chromosome placement that, in turn, results in abnormal oocyte 
division and embryo loss prior to implantation. We cannot exclude, however, the possibility that 
the abnormal oocyte cytokinesis at MI and MII, as demonstrated by larger polar bodies, may 
result in loss of resources required for proper embryo development, and that this may contribute 
to the embryonic loss prior to implantation. Furthermore, the fact that these embryos are 
themselves heterozygous for Erk1 and Erk2 could suggest that ERK-dependent events in the 
oocyte are essential for survival of the post-fertilization pre-implantation embryo, and that any 
potential rescue by paternal Erk gene expression is inadequate or mis-timed.  
Our studies also demonstrate for the first time that ERK signaling in the oocyte is required for 
phosphorylation of at least one downstream target, MSK1, whose localization on the MII spindle 
is, in turn required for phosphorylation of histone H3. Our data point to an essential role for 
phosphorylated histone H3 in maintaining spindle integrity at the second meiotic division. Loss 
	  	  
91	  
of this MSK1-mediated phosphorylation event leads to disrupted MTOC structure, and an 
inability to properly assemble chromosomes on the MII spindle, and subsequent aneuploidy 
leading to pre-implantation embryonic demise.  Thus, our data indicate that ERK signaling, 
while not required for oocyte activation per se, is instead essential for the assembly and normal 
function of the MII spindle in the mammalian oocyte.  
Previous studies with upstream pharmacological inhibitors (Petrunewich, Trimarchi et al. 2009) 
and antisense oligomers (Ou, Li et al. 2010) have shown the involvement of the ERK pathway 
and other MAPK modules in these events but so far, specific involvement of ERKs have not 
been studied. Moreover, while previous studies on ERK disruption in oocytes have demonstrated 
severe spindle defects, such studies involving the use of pharmacological inhibitors are limited 
by factors such as cell permeability, necessitating the use of much higher concentrations (100-
1000 fold) than cell free assays (MacKintosh and MacKintosh 1994). This may have an effect on 
the severity of spindle disruption phenotype displayed in these results. Our use of oocyte-specific 
genetic knockout of ERKs provides an insight into the action of these kinases on spindle 
dynamics and also provides a method for continued assessment of the action of possible 
downstream targets of ERKs, including those that involve MSK1-driven alterations in histone 
status.  
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6. Supplementary Materials 
Figure 3.S1. Evaluation of estrous cycle duration and resumption of meiosis in Erk1/2 DKO 
females. (A) Estrous cycle length determined in each genotype by taking average of estrous 
duration in each animal. Values found to be non-significant by Student t-test, p= 0.98. (B)  
Estrous cycles were assessed by the type and abundance of cells in the vaginal smear of each 
genotype. Erk1 SKO (n= 17) and Erk1/2 DKO (n= 23). (C) Mating efficiency of Erk1 SKO (n= 
8) and Erk1/2 DKO (n= 8) measured by the presence of vaginal plugs. (D) Percentage of oocytes 
showing germinal vesicle breakdown in each genotype. Wildtype (n=15), Erk 1-/- (n=16) and Erk 
1/2 DKO (n= 13). Statistical comparisons using one-way ANOVA, p= 0.106. 
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Figure 3.S2. Dimensions and position of the MII spindle in Erk1 SKO and Erk1/2 DKO 
oocytes. (A) Width of the spindle measured in the middle at the widest part from wildtype 
controls (n= 20), Erk1 SKO (n= 20) and Erk1/2 DKO (n= 18). Bars represent mean + SEM. One-
way ANOVA with Tukey’s multiple comparison test showed p= 0.001 with significant 
difference between Erk1-/- and wildtype spindle length. (B) Distance of the MII spindle from the 
cortex of the oocyte from wildtype controls (n= 4), Erk1 SKO (n= 12) and Erk1/2 DKO (n= 9). 
Bars represent mean + SEM. Kruskal-Wallis test used p= 0.075 
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Figure 3.S3. Total MSK1 and spontaneous release from MII arrest in Erk1/2 DKO oocytes. 
(A) Presence of Total MSK1in oocyte lysates confirmed by western blot. Wildtype and Erk1/2 
DKO oocyte pools of 80 oocytes each in adjacent lanes, probed by MSK1 antibody showing 
band (~ 90kDa) in both the wildtype and the Erk1/2 DKO lanes. Tubulin used as loading control 
(~50kDa). (B) Percentage of oocytes showing spontaneous entry into Anaphase II. Wildtype 
(n=72), Erk1 SKO (n= 67) and Erk1/2 DKO (n= 73) where n is the number of oocytes counted in 
each group. Kruskal-Wallis test used p= 0.104 
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8. Addendum* 
8.1 Analysis of karyotype to detect possible aneuploidy in embryos from Erk1/2 DKO 
oocytes 
I hypothesized that any abnormality in the spindle morphology is likely to produce chromosome 
segregation defects and consequently, aneuploidy. Mis-segregation/misalignment in the oocyte is 
likely to produce embryos that get progressively more aneuploid with each mitotic division, 
ultimately resulting in embryo death. Since embryo death at each stage of cell division was the 
hallmark of our Erk1/2 DKO oocytes, I analyzed the chromosome number of these oocytes and 
the embryos formed from them after fertilization. In addition to having less compact 
chromosomes at the metaphase mid-plate (Chpater2, Fig 1), some of the Erk1/2 DKO oocytes 
exhibited a much higher number of chromosome univalents at metaphase II (Fig 6a). In order to 
detect aneuploidy in embryos, chromosome spreads from the blastomeres of wildtype blastocysts 
(Wt X Wt) and Erk 1/2 DKO blastocysts (Erk1/2 DKO X Wt) were compared. Blastomeres were 
arrested at mitotic metaphase by colcemid treatment. However, due to inadequate number of 
blastocysts from the Erk1/2 DKO oocytes, a comparison was not possible (Fig 6b).  These results 
point to aneuploidy in the embryos derived from the Erk1/2 DKO oocytes, however, more 
analysis is required to conclusively demonstrate aneuploidy as a cause of embryo death.  
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Fig 3.6. Detection of aneuploidy in Erk1/2 DKO oocytes 
MII arrested oocytes from wildtype control (n= 10) and Erk1/2 DKO (n= 10) animals were 
immunolabelled with antibody against phospho-H3S10 (FITC conjugated) and with DAPI to 
visualize chromatin. 
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8.2 Analysis of the effect of ERK deletion on metaphase II arrest in oocytes 
Mammalian oocytes stay arrested in metaphase II till fertilization with the help of an anaphase 
inhibitor known as EMI2 (Early mitotic inhibitior2) (Madgwick, Hansen et al. 2006). For 
maintaining MII arrest till fertilization, EMI2 is stabilized by a series of phosphorylations. In 
Xenopus oocytes these phosphorylations are brought about by p90Rsk (Bhatt and Ferrell 1999). 
It is possible that in the mammalian oocyte this stabilization is mediated by MSK1 instead. EMI2 
phosphorylation by MSK1 has been demonstrated in vitro and the use of pharmacological 
inhibitors of MSK1 produces disruption of the metaphase II spindle (Miyagaki, Kanemori et al. 
2011).  
In our Erk1/2 DKO oocytes, although we demonstrate an ERK-MSK1 phosphorylation cascade 
and abnormal spindle assembly at MII, arrest at MII did not seem to be affected. A number of 
Erk1/2 DKO oocytes show spontaneous entry into anaphase II; however, their numbers were not 
significantly different from wildtype controls (Fig 7). However, this might change when more 
replicates make the data statistically sound. If that is the case, then mis-segregation of 
chromosomes that is seen in the Erk 1/2 DKO oocytes could likely be the result of premature 
entry into anaphase in addition to the other effects observed. 
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Fig 3.7. Spontaneous release from MII arrest in the Erk1/2 DKO oocytes 
Percentage of spontaneous release from MII arrest was calculated in oocytes from wildtype 
controls (n= 72), Erk1 SKO (n= 67) and Erk1/2 DKO (n= 73). Bars represent mean + SEM. 
Statistical comparisons were performed using t-test. 
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CHAPTER 4 
Erk1/2 deletion disrupts downstream effector elements required for oocyte meiotic 
progression and cytokinesis 
1. Abstract 
ERKs are known to be critical upstream regulators of spindle assembly formation and function 
during meiosis. Disruption of ERK activity in the oocyte can bring about significant structural 
anomalies in the spindle and chromosome segregation defects. ERKs are known to localize on 
the spindle microtubules and on the spindle poles. While not much is known about the nature of 
action of ERKs on the spindle, in recent years several proteins have been detected on the spindle 
proteome. It is possible that phosphorylation events play a role in keeping these proteins 
functioning in an efficient, timely way. We have utilized a conditional genetic approach to create 
on an Erk1 null background, an Erk2 deletion specifically in mouse oocytes prior to meiotic 
resumption. Using an antibody that detects ERK mediated phosphorylation we have 
demonstrated a reduction in phosphorylation in the Erk1/2 double knockout oocyte. Analysis of 
the reduced phosphorylation revealed a series of different proteins with possible interaction with 
the MAPK pathway. Based on number of protein hits, molecular weight and presence of 
serine/threonine phosphorylation sites, the list was narrowed down to a few possible candidates.  
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These proteins, namely BUBR1, TACC3, NLRP5, KIF23, DNMT1 all have been shown to have 
action on the spindle in mitotic cells. This study is aimed at elucidating several possible targets 
of ERK1 and ERK2 in the oocyte spindle assembly using an immunohistochemical and a mass 
proteomics approach.  
 
2. Introduction 
Post prophase I meiotic divisions in mammalian oocytes are characterized by a strictly 
coordinated set of key events leading to the formation of a spindle –chromosome complex 
(SCC). A spindle-chromosome complex is an assembly of microtubules attached to the 
kinetochores of chromosomes anchored by spindle poles. Oocyte meiosis requires the 
coordinated formation of a bipolar spindle, maintenance of proper microtubule chromosome 
attachment, tension on the bipolar spindle, migration of the spindle to the cortex and functioning 
spindle assembly checkpoint (Vogt, Kirsch-Volders et al. 2008). Formation of a bipolar spindle 
with correct microtubule kinetochore attachment ensures faithful chromosome segregation 
thereby ensuring genomic integrity of daughter cells (Ai, Wang et al. 2008). Regulated spindle 
movements and migration ensures asymmetric division in the female germ cell, which helps in 
the retention of the cytoplasmic reserves for the embryo. Checkpoint controls are in place to 
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ensure error-free progression of the above-mentioned events. The spindle assembly checkpoint 
(SAC) monitors the tension exerted by the pulling forces of the microtubules on the 
chromosomes and interrupts cell cycle progression in cases of abnormal assembly to prevent 
aneuploidy in the developing embryos (Cross and Smythe 1998).  
A spindle apparatus is formed from the Microtubule Organizing Centers (MTOC), ring shaped 
structures that eventually form what are known as the spindle poles (Verlhac, de Pennart et al. 
1993; Ou, Li et al. 2010). One of the components of MTOCs is ɣ tubulin, which functions as the 
positive end of microtubules. α and β tubulin molecules form dimers, which then polymerize 
into long microtubules. The negative ends of these microtubules grow away from MTOCs or 
poles towards chromosomes where they bind to the kinetochore in the centromeric region 
(Figure 1) (Walczak and Heald 2008). Once attached to the kinetochore, the microtubules exert 
tension on the condensed chromosomes, keeping them aligned at the metaphase plate (Walczak 
and Heald 2008). At the onset of anaphase, cohesive forces keeping chromosomes together are 
severed and the chromosomes are pulled apart to each pole. The positioning of the spindle within 
the oocyte is also very important for the asymmetric cytokinesis that takes place during oocyte 
meiosis (Sun, Lai et al. 2001).  
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Figure 4.1. Formation of spindle assembly at metaphase 
α and β tubulin dimers polymerize from the MTOCs which function as anchoring points for the 
positive ends of microtubules. The growth of the microtubules is towards the metaphase plate 
where chromosomes assemble after condensation. The microtubules then attach to the 
kinetochores of the chromosomes to bring about bipolar orientation of the spindle. Several 
proteins are involved in the formation, maintenance and function of the bipolar spindle, which 
are activated or deactivated at specific time points in order to regulate their timed functions. 
Most of these activations/ deactivations are brought about by phosphorylations by various 
kinases. MAPKs are thought to play a major role in this regulation. 
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Numerous proteins associate with the spindle to regulate its formation, function and 
maintenance. Many of them are motor proteins such as kinesins and dyneins that function to 
transport other molecules along microtubules, and help in microtubule and chromosome 
movement. Other proteins are microtubule associated proteins that function in stabilizing and 
destabilizing microtubules, cross-linking parallel strands of microtubules and guiding their 
direction of polymerization. Still others, such as members of the SAC (Spindle Assembly 
Checkpoint), ensure error-free progression of spindle function. Finally, there are several 
signaling proteins such as kinases and phosphatases that regulate and coordinate the temporal 
and spatial organization of the spindle.  A proteomic analysis of the mammalian oocyte spindle 
using LC-MS/MS (Liquid chromatography Mass Spectrometry) recovered about 600 proteins 
with the spindle assembly of which about 200 were associated with the spindle-chromosome 
complex (Han, Liang et al. 2010). Similarly, a large-scale phosphoproteome analysis of the 
human mitotic spindle using mass spectrometry in combination with phosphopeptide enrichment 
has revealed approximately 600 proteins and 2000 unique phosphorylation sites associated with 
the spindle (Nousiainen, Sillje et al. 2006). Several of these phosphorylation sites have been 
identified as corresponding to consensus motifs of kinases such as CDK1, PLK1, AURK A/B etc 
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(Nousiainen, Sillje et al. 2006). However, not much is known about the role of MAPK on the 
spindle phosphoproteome.  
Previous work has shown that disruption of ERK/MAPK pathway produces drastic spindle 
defects and chromosome segregation defects in the oocyte. These results also point to a possible 
defect in spindle cytokinesis owing to the improper migration of spindle assembly in the oocyte. 
So, in order to delineate the exact mechanism of action of ERKs in regulating spindle assembly, 
we used an oocyte specific Erk deletion model to study the downstream pathways affected in the 
absence of ERKs leading to previously defined spindle defects. For this, we employed a very 
specific LoxP-Cre recombinase mediated conditional deletion of Erk2 in the oocyte on an Erk1 
null background. 
Analysis of the phosphorylation status of certain proteins of the SAC in both the wildtype and 
the Erk1/2 DKO oocytes indicated their possible interaction with the ERK/MAPK pathway to 
bring about spindle assembly. Components of the SAC are believed to interact with the MAPK 
pathway (and other signaling cascades) to prevent activation of the anaphase-promoting complex 
during metaphase. Function of the SAC to prevent anaphase might require the action of a MAPK 
cascade in order to co-ordinate and choreograph various simultaneous events involved in the 
proper functioning of the SAC. These events include possible activation of the SAC proteins and 
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transportation to and from various sites on the spindle. And because ERKs might play an 
important role in the function of SAC proteins, absence of ERKs can cause possible inhibition 
(or lack of activation) of the SAC in the oocyte, leading to abnormal chromosome segregation. 
In addition to the proteins of the SAC, delineation of other possible downstream ERK targets is 
also described in this study. These possible ERK targets provide a basis for defining factors 
involved in the spindle function. 
 
3. Materials and Methods 
3.1 Generation of the Erk2 fl/fl Erk1-/- mouse  
 Wildtype control mice and Zp3-Cre mice were obtained from Jackson Laboratories. The 
Erk1 knockout strain (Erk2 fl/fl Erk1-/-) have been reported in previous study (Bliss, Miller et al. 
2009). Mice with Erk 1/2 double deletion in oocytes were generated by crossing Zp3-cre line 
with the Erk2fl/fl Erk1-/- line. All experiments were performed with wildtype, Erk1 SKO (Erk1 -/-) 
and Erk1/2 DKO (Erk2 fl/fl Zp3Cre+/- Erk1 -/-) animals. All the mice used in this study are on a 
C57BL/6 background. Animals were housed according to the Cornell University Institutional 
Animal Care and Use Committee regulations. 
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3.2 Genotyping 
 Tail snips were used as a source of genomic DNA. PCR genotyping strategies for Erk1 
and Erk2 were performed as described previously (Bliss, Miller et al. 2009). Cre PCR for 
confirming the recombination at Erk2fl/fl employed the following primers- 
Forward:GTCGATGCAACGAGTGATGAGGTTCG and 
Reverse:CCAGGCTAAGTGCCTTCTCTACACCTGC. 
3.3 Oocyte retrieval and culture 
For assessment of MI and MII spindle structures, oocytes were collected from ovaries of 21-day-
old mice by follicle puncture with a 26.5 gauge needle in M2 medium containing hyaluronidase 
(MR 051F, EMD Millipore, Billerica, MA). For superovulation, 4 week old females were 
injected with PMSG (5 IU, i/p) followed by hCG (5IU, i/p), and oocytes were collected from 
oviducts the following morning. The oocytes were then transferred to M2 medium without 
hyaluronidase (MR 015D, EMD Millipore, Billerica, MA) and finally to KSOM medium (MR 
020P, EMD Millipore, Billerica, MA) under oil in a 35 mm culture dish. The oocytes were then 
incubated in conditions of 5% O2 and 5% CO2 at 37C for specific time periods: MI (~8hrs) and 
MII (16hrs). MII stage was confirmed by the presence of a polar body.  
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3.4 Immunofluorescent labeling 
Oocytes were fixed in buffer containing 2% PFA, blocked for 1 hour at room temperature and 
incubated in primary antibody overnight at 4C. Oocytes were then washed, incubated in 
secondary antibody at room temperature for 1 hour and mounted in Antifade containing DAPI. 
The cover glass was fixed over the slide using a 1:1 mixture of paraffin and petroleum jelly. 
Antibodies used were mouse anti-beta tubulin (T8328, Sigma-Aldrich, St Louis, MO), Rabbit 
anti-ERK 1/2 (4695, Cell Signaling Technology, Boston, MA), mouse anti-Gamma tubulin 
(ab27074, Abcam, Cambridge, MA), Rabbit anti-RSK1/RSK2/RSK3 (32D7) (9355P, Cell 
Signaling Technology, Boston, MA), Rabbit anti- Phospho-p90RSK  (Thr359/Ser363), (9344P 
Cell Signaling Technology, Boston, MA), Rabbit anti- Phospho-p90RSK  (Thr573) (9346P Cell 
Signaling Technology, Boston, MA), Rabbit anti-TACC3 (D9E4) XP mAb (8069, Cell Signaling 
Technology, Boston, MA), Rabbit anti-Phospho-TACC3 (Ser558) (5645, Cell Signaling 
Technology, Boston, MA), Rabbit anti-BubR1 antibody-N-terminal (ab135682, Abcam, 
Cambridge, MA), Rabbit anti-Mad2L1 antibody (ab24588, Abcam, Cambridge, MA) and Mouse 
anti-MPM-2 (05368, EMD Millipore, Billerica, MA). 
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3.5 Western Blotting 
For protein detection with western blot, oocytes were pooled from 4-6 week old superovulated 
female mice and lysed in 2X Laemelli buffer. Samples were immediately boiled at 95C and 
cooled on ice. Proteins were separated in an SDS-PAGE electrophoretic system and transferred 
onto Immuno-Blot PVDF membrane (162-0177, BioRad, Hercules, CA). Membranes were 
probed with mouse anti-beta tubulin (T8328, Sigma-Aldrich, St Louis, MO), Rabbit anti-ERK 
1/2 (4695, Cell Signaling Technology, Boston, MA), mouse anti-Gamma tubulin (ab27074, 
Abcam, Cambridge, MA), Rabbit anti-RSK1/RSK2/RSK3 (32D7) (9355P, Cell Signaling 
Technology, Boston, MA), Rabbit anti- Phospho-p90RSK  (Thr359/Ser363), (9344P Cell 
Signaling Technology, Boston, MA), Rabbit anti- Phospho-p90RSK  (Thr573) (9346P Cell 
Signaling Technology, Boston, MA), Rabbit anti-TACC3 (D9E4) XP mAb (8069, Cell Signaling 
Technology, Boston, MA), Rabbit anti-Phospho-TACC3 (Ser558) (5645, Cell Signaling 
Technology, Boston, MA) and Mouse anti-MPM-2 (05368, EMD Millipore, Billerica, MA) 
according to manufacturer instructions.  
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3.6 Immunoprecipitation 
Oocyte lysates were prepared by sonicating ~500 superovulated oocytes in cold RIPA plus 
buffer 3 times at 20% amplitude for 10 sec each. Lysate was pre-cleared by incubation with 
Protein A/G PLUS-Agarose beads (sc-2003, Santa Cruz Biotechnology, Dallas, Texas). Pre-
cleared lysates were then incubated with 1:200 Mouse anti-MPM-2 (05368, EMD Millipore, 
Billerica, MA) and subsequently with Protein A/G PLUS-Agarose beads. Proteins were extracted 
from the Protein A/G PLUS-Agarose beads by boiling at 95C for 10 minutes. Proteins were 
separated in an SDS-PAGE electrophoretic system and transferred onto a Immuno-Blot PVDF 
membrane (162-0177, BioRad, Hercules, CA). Membranes were then probed with mouse anti-
MPM-2 (05368, EMD Millipore, Billerica, MA). 
3.7 Sample preparation for Liquid chromatography- Mass spectrometry (LC-MS) 
Lysates were prepared from~1500 oocytes and immunoprecipitated with anti-MPM-2 antibody 
as described above. The sample was subjected to electrophoresis on a 12% SDS-PAGE gel. Gel 
was fixed for 30 minutes in 45% methanol, 45% water, and 10% glacial acetic acid (Fixing 
solution) and then moved to 7% methanol, 83% water, and 10% glacial acetic acid (Storage 
solution). The gel in storage solution was delivered to the Cornell Proteomics facility where it 
was stained with Sypro Ruby. Bands at ~130 kDa and ~80 kDa were excised and used for LC-
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MS. Results were searched using Mascot® against the Mouse Reference Sequence with a 
confidence threshold of 99% and an ion cutoff score of 20. 
3.8 Statistical analysis 
Statistical analysis of experiments was done by student t-test and analysis of variance as 
applicable. All statistical tests were performed using Prism 4.0 software (Graphpad). 
3.9 Microscope image acquisition 
Acquisition and processing of images was performed by microscope (Imager Z1; Carl Zeiss, 
Inc.) under a 10x eye-piece and 40× 0.5 NA ECPlan Neofluar air immersion (Carl Zeiss, Inc.) or 
63× 1.4 NA Plan Apochromat oil immersion (Carl Zeiss, Inc.) magnifying objective at room 
temperature, cooled charged-coupled device camera (AxioCam MRm; Carl Zeiss, Inc.) and 
AxioVision software (version 4.7.2; Carl Zeiss, Inc.). Images were analyzed using ImageJ 
program (ImageJ64.app, NIH).  
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4. Results and Discussion 
 
4.1 Analysis of the Spindle Assembly checkpoint (SAC) proteins in the Erk 1/2 DKO 
oocytes 
Components of the SAC are believed to interact with the MAPK pathway (and other signaling 
cascades) to prevent activation of the anaphase-promoting complex during metaphase. In 
Xenopus oocytes, for instance, Bub1 is activated by p90Rsk mediated phosphorylation (Schwab 
MS 2001), while BUBR1 in the mouse SAC is inhibited by p38 mediated phosphorylation (Wei 
L 2010). In addition to this, several indirect interactions with MAPK components are also 
believed to take place for SAC function. For example, localization of BUB3 on kinetochores is 
dependent on PARP1, which in turn, requires possible MAPK regulation (Yang F 2009). 
Similarly, Dynein, a motor protein required for transportation of the SAC proteins along the 
microtubules, is phosphorylated on a highly conserved serine residue by ERKs (Bader JR 2010; 
Pullikuth AK 2013). 
Inhibition (or lack of activation) of the SAC in the absence of ERKs, may lead to imperfect 
attachment of the kinetochores to the spindle microtubules causing improper assembly of the 
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spindle. Lack of SAC activation in the absence of ERKs may also cause abnormal exit from 
metaphase before all chromosomes are aligned properly on the metaphase plate, leading to 
abnormal chromosome segregation. 
Immunostaining of BUBR1, a major component of the mammalian SAC, on wildtype oocytes 
and Erk 1/2 DKO oocytes showed absence of this protein on the spindle of either genotype (Fig 
2). There is no discernible pattern of localization of BUBR1 protein on either wildtype (Fig 2 
Left panel) or Erk 1/2 DKO (Fig 2 Right panel) oocytes. This might indicate a lack of SAC 
activation in both the wildtype oocyte (due to error-free completion of meiosis) and in the Erk 
1/2 DKO oocytes (due to absence of ERKs that may be required for SAC activation). However, 
it should be noted that this data is very preliminary and further analysis is essential to understand 
this phenomenon of inhibition (or lack of activation) of the SAC in the absence of ERKs, leading 
to abnormal chromosome segregation.  
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Fig 4.2. Immunostaining of BUBR1 
Localization of BUBR1 protein in MII arrested oocytes from wildtype control and Erk1/2 DKO 
animals with antibodies against BUBR1 (FITC conjugated) and β-tubulin (Texas-red 
conjugated).   No discernible pattern of localization of BUBR1 protein on either wildtype (Left 
panel) or Erk 1/2 DKO (Right panel) oocytes observed. 
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4.2 Identification of other potential ERK phosphorylation targets in mammalian oocytes 
In order to ascertain and assess localization of possible downstream targets, an ERK specific 
phosphorylation detection antibody was used to immunostain oocytes. MPM2 (Mitotic Protein 2) 
is an antibody that detects proline directed serine threonine phosphorylation in mitotic cells. A 
proline directed serine/threonine type of phosphorylation is characteristic of the kinases ERK1 
ERK2, CDK1 and certain other kinases. Some of the major known substrates of MPM2 in 
mitotic cells are Topoisomerase IIα, MAP (Microtubule associated proteins) and NIMA (Renzi, 
Gersch et al. 1997). Since Erk1/2 DKO oocytes are expected to show normal expression of 
CDK1 and other kinases, any difference in MPM2 staining is likely due to the deficiency in ERK 
activity.  
Immunostaining of Erk1/2 DKO oocytes revealed prominent absence of MPM2 substrates from 
the MII spindle assembly. (Fig3a). This indicates that potential targets for ERK phosphorylation 
are present in the oocyte at Meiosis II and that these targets are possibly involved in spindle 
assembly and function. In order to further determine the nature of target molecules, I compared 
the expression of phosphorylated proteins in oocyte lysates from wildtype, Erk1 SKO and Erk1/2 
DKO animals. Lysates were subjected to gel electrophoresis and probed with MPM2 antibody. 
Of the multiple protein bands detected by this antibody, one band that migrated at approximately 
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120-130 kDa showed a significant reduction in the Erk1/2 DKO lysates as compared with the 
wildtype and Erk1 SKO lysates. The Erk1 SKO lane itself showed a slightly lower band intensity 
when compared to the wildtype at 120-130 kDa, indicating that any phosphorylation deficiency 
caused by Erk1 deletion cannot be fully compensated by Erk2 (Fig 3b). 
To identify proteins within the 120-130 kDa range of molecular weight that in mouse oocytes, 
Liquid Chromatography - Mass Spectrometry assay (LC-MS) was employed. For this, 
immunoprecipitation of wildtype oocyte lysates was performed with the MPM2 antibody. 
Western blot of immunopreciptated material showed the presence of a strong band at the 120-
130 kDa range. Next, the MPM2 immunoprecipitate from 1500 wild type oocytes was run on a 
5% SDS-PAGE gel. The gel was then stained with Sypro Ruby and a region of gel 
corresponding to 130 kDa and 80 kDa (for comparison) and analyzed by LC-MS. The two bands 
were searched using Mascot Distiller (Version 2.2) against Mouse reference sequence. A second 
replicate was also performed with 1500 oocytes. Fifty-one (51) and forty-seven (47) proteins 
were identified from each band, respectively; in the first replicate and seventy-one (71) and 
thirty-three (33) respectively in the second replicate (Appendix 1).  
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Fig 4.3. Erk1/2 DKO oocytes show absence of MPM-2 substrates  
(a) Localization of total MPM2 protein substrates on meiotic spindles of MII arrested oocytes 
from wildtype control and Erk1/2 DKO animals with antibodies against MPM2 (Cy5 
conjugated). MPM2 signal absent from Erk1/2 DKO oocyte spindle (Yellow arrowhead).  Scale 
bar 10 µm.  (b) MPM2 substrates in oocyte lysates confirmed by western blot. Wildtype and 
Erk1/2 DKO oocyte pools of 100 oocytes each in adjacent lanes, probed by MPM2 antibody (~ 
130kDa) in the wildtype lane and absence of bands in the Erk1/2 DKO lanes (Red arrowhead).  
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From these LC-MS results, potential protein targets were identified based on a) Number of 
protein hits b) Approximate molecular weight or MW at which the protein travels during 
electrophoresis and c) Presence of proline directed phosphorylation sites.  
4.3 Possible downstream effectors involved in spindle assembly and function 
Several interesting proteins were identified from the LC-MS results, which are discussed here. 
The discussion below describes the candidate protein, known functions of the protein in spindle 
assembly, possible interaction with MAPKs, whether present in the mammalian oocyte and a 
mutant phenotype, if any.  
4.3.1 TACC3 (Transforming Acidic Coiled Coil 3) is a centrosomal protein involved in mitotic 
cell function. Phosphorylated TACC3 has been shown to increase microtubule stability and 
regulate chromosome alignment in mitotic cells (Schneider, Essmann et al. 2007). TACC3 has 
several Serine/Threonine phosphorylation sites and many kinases have been implicated in their 
activation such as TPX2 (Serine 558), Aurora kinase A (also Serine 558) etc (Schneider, 
Essmann et al. 2007). RNAi directed TACC3 depletion in mitotic cells showed aberrant spindle 
morphology, misaligned chromosomes and aneuploidy (Schneider, Essmann et al. 2007; Yurttas 
P 2010). Two-dimensional gel electrophoresis showed the presence of TACC3 in GV stage 
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oocytes in the mouse, indicating its importance in oocyte function (Hao, Stoler et al. 2002; 
Yurttas P 2010).  
4.3.2 KIF23- Kinesin-like protein 23 is a member of the Kinesin-like family of the Kinesin 
super-family of proteins. They are microtubule associated motor proteins that are central to the 
formation of the spindle mid-zone for proper assembly of chromosomes during cell division 
(White and Glotzer 2012). KIF23 is known to form the spindle mid-body by interconnecting 
parallel microtubules to stabilize them (Zhu, Bossy-Wetzel et al. 2005).  Many kinases such as 
Aurora B and CDC2 have been implicated in the phosphorylation of KIF23. However none of 
these have been shown to be essential for KIF23 function. KIF23 may also have multiple 
phosphorylation sites (Zhu, Bossy-Wetzel et al. 2005). siRNA knockdown of KIF23 and its 
recruiting protein INCENP in human mitotic cells produced abnormal cytokinesis and 
chromosome segregation indicating that it is essential for these processes (Vernos, Heasman et 
al. 1993; Minestrini, Mathe et al. 2002). Though not much is known about the exact functions of 
KIF23 in the oocyte, it has been found in the transcriptome of oocytes in Xenopus and 
Drosophila and during oogonial division in mouse (Greenbaum, Iwamori et al. 2009).  
4.3.3 Junction plakoglobin is also known as Ƴ-catenin and is closely related to β-catenin. It is 
found in association with β catenins and cadherin proteins in cell membranes and is involved in 
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cell-to-cell adhesion (Kofron, Heasman et al. 2002). In Xenopus, plakoglobin has been shown to 
be required for maintenance of the cortical actin cytoskeleton. Depletion of plakoglobin in 
Xenopus embryos leads to loss of embryo shape and architecture (Kofron, Spagnuolo et al. 
1997). Plakoglobin has also been found in Zebrafish oocytes where it likely plays a role in 
follicle development and interaction with granulosa cells. While the kinase regulators of 
plakoglobin are not known, it has been shown to have multiple serine/threonine phosphorylation 
sites in vivo which affect the stability of the protein (Pasdar, Li et al. 1995; Cerda, Berrios et al. 
1999). 
4.3.4 DNMT1 (DNA (cytosine-5) methyl transferase 1 isoform 2) - DNA methyl transferases are 
proteins required for DNA methylation. DNMT1 disruption in human cancer cells showed an 
accumulation of tetraploid cells in G2 arrest possibly due to the failure of cytokinesis (Chen, 
Hevi et al. 2007). DNMT1 depletion by RNAi produced aneuploidy and chromosome instability 
(Barra, Schillaci et al. 2012). Over expression of DNMT1 in human and mouse fibroblasts have 
shown defective spindle morphology and tumorogenicity (McCabe, Low et al. 2006). The 
enzymatic activity of DNMT1 is dependent upon the phosphorylation status of its various 
Serine/Threonine residues. While some cyclin dependent kinases have been implicated in this, 
the exact pathway of DNMT1 activation is poorly understood (McCabe, Low et al. 2006). 
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DNMT1 is present in the mammalian oocyte in all stages of development and has been shown to 
be crucial for early embryonic development (Lodde, Modina et al. 2009). 
4.3.5 PARG - Poly (ADP-ribose) glycohydrolase is an enzyme responsible for the degradation 
of Poly (ADP-ribose) or PAR, a large polymeric macromolecule required for spindle assembly 
and function (Finch, Knezevic et al. 2012). PARG have been shown to localize on the mitotic 
spindle and is required for the timely degradation of PARs after spindle formation (Chang P 
2004). PARG null mice show embryonic lethality and PARG null cells show high rates of 
apoptosis (Finch, Knezevic et al. 2012). In drosophila disruption of PAR degradation by PARGs 
can cause defects in oocyte development and infertility (Ji and Tulin 2012).  
4.3.6 NLRP5 or MATER (NACHT, LRR and PYD domains containing protein 5) is a maternal 
affector protein that function in cytoplasmic lattice formation (Kim, Kan et al. 2010). Nlrp5-/- 
oocytes display 2-cell stage arrest after fertilization (Tong, Gold et al. 2000). Deletion of a 
downstream effector of NLRP5, PtdIns (3,4,5)P3 disrupts asymmetric division of oocytes due to 
impaired regulation of F-actin organization and spindle translocation (Zheng, Baibakov et al. 
2013).  
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4.4 Detection of TACC3 in Erk1/2 double Knockout oocytes 
Of the above-mentioned putative downstream targets of ERKs, TACC3 showed a high number 
of protein hits and very high number of S/T phosphorylation sites. And hence, TACC3 was 
chosen as the first putative target for analysis in the Erk1/2 DKO oocytes. To determine the 
presence of total TACC3 and its phosphorylation activity in the oocyte, I performed 
immunocytochemistry using TACC3 antibodies on MII stage oocytes. Total TACC3 localization 
was observed to be on the spindle in MII oocytes (Fig4a). Erk1/2 DKO oocytes showed similar 
localization of TACC3 on the MII spindle. Commercially available antibodies for the detection 
of phosphoTACC3 use p-serine 558 as the epitope for detection. While Ser 558 is known to be 
one of the target sites for Aurora A Kinase-mediated phosphorylation in mitotic cells, it has been 
implicated in other phosphorylation pathways in mammalian meiotic oocytes. Phosphorylated 
TACC3 plays a role in chromosome alignment, segregation and cytokinesis (Schneider, Essmann 
et al, 2007).  
Antibody directed against phosphoTACC3 serine 558 did not show any localization on the 
spindle of MII oocytes. However, there was a disseminated signal indicating a generalized 
distribution of the protein in the whole oocyte cytosol of wild type oocytes, which was absent in 
the Erk1/2 DKO oocytes (Fig 4a). 
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Protein detection by western blot and comparison between wildtype and Erk1/2 DKO oocyte 
protein lysates when probed with phospho-TACC3 however was inconclusive (Fig 4b). 
However, this could be because TACC3 is a heavily phosphorylated protein with multiple serine 
and threonine phosphorylation sites. While there is some information regarding Serine 558, the 
extent of ERK activity on Ser 558 is poorly understood. Moreover, other phosphorylation sites 
on TACC3 such as S25, S317, T30 etc, and their upstream phosphorylating kinases remain 
unknown. Therefore, a more thorough quantitation of the TACC3 phosphorylation profile of 
oocytes is essential both through in vitro and in vivo methods. Importantly, the changes in 
phosphorylation states of TACC3 in absence of ERK will help understand the role of these 
kinases in TACC3 mediated spindle stability. 
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Fig 4.4. TACC3 immunochemistry 
(a) Localization of total TACC3 protein and phosphorylated TACC3 (Ser 558) on meiotic 
spindles of MII arrested oocytes from wildtype control and Erk1/2 DKO animals with antibodies 
against TACC3, phospho- TACC3 (FITC conjugated) and β-tubulin (Texas-red conjugated).   
(b) Analysis of phospho-TACC3 by western blot. Wildtype and Erk1/2 DKO oocyte pools of 
100 oocytes each in adjacent lanes, probed by pTACC3 antibody in the wildtype lane and in the 
Erk1/2 DKO lanes. Bands at 140 KDa marked by yellow arrowheads. Tubulin used as loading 
control. 
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4.5 Analysis of Ribosomal s6 Kinases in Erk1/2 double knockout oocytes 
Studies delineating the MAPK pathway in Xenopus oocytes have always pointed to RSK (also 
known as p90RSK or ribosomal s6 kinase) as the most crucial downstream effector of MAP 
Kinases (Bhatt and Ferrell 1999). However, Rsk1,2,3 triple knockout studies in the mouse have 
demonstrated no defects in the spindle morphology or meiotic function of oocytes, indicating 
that RSKs are not essential in the mouse (Dumont J 2005). Since we have already demonstrated 
an ERK-MSK1 mediated phosphorylation in the oocyte (See Chapter 2), I decided to look at 
these closely related kinases RSK1/2/3 in the Erk1/2 DKO oocyte. Total RSK, phospho-RSK 
localization and levels within the oocyte were assessed by immunostaining and western blots 
respectively. Neither total RSK nor phospho-RSK showed any specific localization patterns in 
the oocytes (Fig 5). There was no significant difference in these patterns between the wildtype 
and Erk 1/2 DKO oocytes either (Fig 5A-D). These results suggest that deletion of Erk1/2 does 
not affect RSKs, indicating that they may not be direct ERK targets in the murine oocyte.  
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Fig 4.5. RSK, pRSK immunostaining 
Localization of RSK protein in MII arrested oocytes from wildtype control and Erk1/2 DKO 
animals with antibodies against RSK and pRSK (FITC conjugated) and β-tubulin (Texas-red 
conjugated).   Panels show, from left to right, merged images from both flurochromes (i), β-
tubulin (ii) and RSK/pRSK (iii). Panels (A) Wildtype oocytes immunostained with total RSK. 
Merged images from both flurochromes (i), β-tubulin (ii) and RSK (iii). Panels (B) Erk1/2 DKO 
oocytes immunostained with total RSK. Merged images from both flurochromes (i), β-tubulin 
(ii) and RSK (iii). Panels (C) Wildtype oocytes immunostained with phospho RSK. Merged 
images from both flurochromes (i), β-tubulin (ii) and phospho-RSK (iii). Panels (D) Erk1/2 
DKO oocytes immunostained with phospho RSK. Merged images from both flurochromes (i), β-
tubulin (ii) and phospho RSK (iii). 
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5. Conclusions 
An important possible action of ERKs is on the SAC function. While there are several different 
proteins comprising the SAC, some of the major ones such as BUB and MAD family of proteins 
can be assessed on the oocyte. However, localization of the SAC proteins is transient and so the 
exact temporal localization needs to be pinpointed first, in order to determine if they are absent 
from the Erk1/2 DKO oocyte. Absence of SAC proteins from Erk1/2 DKO oocytes could also 
point to an inability to activate the SAC in the absence of ERKs. Hence a very thorough, time 
specific analysis of the expression profile of oocyte proteome is necessary to assess SAC 
function in relation to the ERK status.  
In order to elucidate possible downstream targets of ERKs a mass proteomic screening was 
employed using an antibody that detects phosphorylations characteristic of ERKs. Of the several 
proteins that showed upon the screen, many are known to be involved in spindle assembly and 
function in mitotic cells. Several of those proteins are reported to show spindle structural 
anomalies in RNAi mediated knockdown studies. A much more detailed examination of each of 
those possible targets is required to assess the extent of their involvement of the oocyte 
Metaphase I and II spindles. Expression of one such protein from the screen, TACC3, was 
further analyzed. However the commercially available antibody for phosphoTACC3 uses only 
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Serine558 as an epitope. Since TACC3 is known to have about 40 Serine/Threonine 
phosphorylation sites, a more thorough in vitro analysis of ERK-TACC3 interaction is essential.  
It has been demonstrated in our work that Erk deletion produces a disruption in the ERK-MSK1-
Histone H3 pathway leading to defects in chromosome condensation and in spindle formation. 
However, ERKs have a multitude of targets within the cell for regulating each step of the cell 
cycle. Therefore, other effectors are likely disrupted in the absence of ERKs. Based on the 
phenotype observed, it is possible that many of these effectors are involved in other aspects of 
cytokinesis such as spindle movement, cytoskeletal rearrangement, SAC function, metaphase II 
arrest etc. a much more detailed and expansive study of ERK targets are required in order to shed 
light on these various downstream pathways.  
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CHAPTER 5 
Discussion and Future Directions 
Mitogen-activated protein kinases or MAPKs translate diverse extracellular signals into various 
cellular responses that are both critical and specific for the physiological function of each cell 
type. MAPK pathways are present in all eukaryotic cells and participate in almost all 
physiological responses of the cell, including division, growth, metabolism, apoptosis, gene 
regulation and differentiation. In order to bring about these diverse biological functions, the 
MAPK system employs several kinases at each step of its phosphorylation cascade, each of 
which have a distinct regulatory function. Together these components act on a variety of 
substrates to bring about a wide range of responses (Cargnello and Roux 2011).  
The goals of my studies were to tease apart the distinct functions of ERK1 and ERK2 within the 
mammalian oocyte, and to differentiate these functions from those of the supporting somatic cell 
lineages.  Furthermore, by using a defined array of Cre-expressing transgenic mouse lines, the 
aim was to delineate these oocyte-specific functions both spatially and temporally, through the 
course of oogenesis.  The use of the Zp3-Cre line described in this thesis was the “proof of 
principle” to show that this exquisite genetic approach would work.  Over the course of this work 
I have demonstrated that ERK1 and ERK2, specifically within the oocyte, play significant roles 
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in the completion of oocyte meiosis, spindle formation, chromosome segregation and 
asymmetric division of the oocytes. In somatic cells ERK1 and ERK2 are known to be global 
signaling molecules exerting transcriptional control over a variety of genes (Saba-El-Leil, Vella 
et al. 2003). Since ERK1/2 have such a wide network of influence over cellular processes, Erk 
deletion in the oocyte at a time as crucial as meiotic resumption, completion and fertilization was 
bound to produce significant changes. In addition to preparation of meiotic resumption after 
dictyate arrest (when Erk deletion occur in our Erk1/2 double knockouts) the oocytes are also 
growing and accumulating proteins and RNA transcripts for later use (Fan and Sun 2004). 
Hence, we postulated early on that Erk deletion at this stage would bring about abrogation of 
multiple protein functions. My studies offer a starting point for this analysis by first pinpointing 
the timeline of events that are dependent on functional ERK signaling following meiotic 
resumption.  A better picture of the entire impact of Erk1/2 deletion will emerge with the use of 
large-scale screening such as whole proteome profiling, whole transcriptome profiling and global 
phosphoproteome analysis of the oocyte. 
In chapter1, I provided an in-depth analysis on the complete genetic network that is active within 
an oocyte during its development from a germ to cell to a fully functional haploid gamete. 
Because of the accelerated pace of technology, it is now possible to delineate several distinct but 
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interconnected gene networks that co-ordinate the various steps in gametogenesis. Each network 
can help shed light on the function of individual components within these set of events. 
Furthermore, it can be seen that most of the events in oogenesis, as well as the genetic networks 
precipitating them, are interconnected with each other. And signaling cascades such as the 
MAPK are what connect them, both with each other as well as with external mitogenic signals. 
This is of particular importance as this tells us that extrinsic factors and the environment may 
influence oogenesis and oocyte function, thereby affecting the reproductive health of an 
individual. 
Next in chapter 2, I summarized the specific connections between MAPK signaling cascades 
within the oocyte and oocyte-specific gene networks. The picture that begins to emerge here is 
that MAPK, specifically ERK1 and 2, are an intrinsic part of most regulatory mechanisms of 
oogenesis and oocyte maturation. From previous literature, it becomes clear that ERKs 
participate in a variety of oocyte specific functions such as germinal vesicle breakdown, 
interaction with the granulosa cell compartment etc. Inhibition of the MAPK cascade upstream 
of ERKs can provide insight into their roles in each oocyte specific event. Such studies have 
shown the involvement of ERKs in asymmetric division of oocytes, spindle formation etc. 
However, all of these studies aimed at the inhibition of the MAPK pathway have utilized 
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pharmacological inhibitors, which produce global inhibition of MAPKs in both somatic and 
germinal compartments of the ovary. While these methods are effective they are not a true 
reflection of in vivo conditions. Moreover, in order to overcome factors such as cell permeability 
etc, very high concentrations of the pharmacological agents need to be used, which would bring 
about a more severe phenotype than that of a knockout due to cytotoxicity (MacKintosh and 
MacKintosh 1994). Knockdown studies using oligos are also not very effective because of 
residual protein within the cell.  
Therefore, in order to investigate the role of ERK1 and ERK2 in the oocyte I generated a mouse 
line with oocyte specific conditional deletion of Erk2 on an Erk1 null background. Previous 
work on ERK1 and ERK2 has shown that these kinases may have non-redundant functions in 
certain tissues. While deletion of Erk1 seems to have no effect on the viability of the mice, Erk2 
deletion causes embryonic lethality (Hatano, Mori et al. 2003). Therefore by using a ZP3 
promoter driving Cre expression, on a background of constitutive Erk1 loss, I produced a model 
for Erk1/Erk2 double knockout (Erk1/2 DKO) oocytes that induces a complete, consistent 
absence of ERK specifically within the oocyte while keeping the rest of the physiological 
parameters of the oocyte intact. 
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In chapter 3, I provide a detailed phenotypic characterization of the Erk1/2 DKO mouse line. 
Erk1/2 DKO oocytes showed a complete absence of total ERKs in the oocyte at all stages of 
development in the postnatal ovary. Due to normal ERK expression in the somatic cells of the 
ovary, the follicle development, ovarian morphology, ovulation and estrous cycles are normal in 
these animals. However, the Erk1/2 DKO females were infertile and exhibited failure of 
implantation. In vitro culture of Erk1/2 DKO oocytes revealed normal meiotic resumption -as 
expressed by normal GVBD rates-and meiotic progression through MI and MII. A normal 
GVBD rate was expected in these oocytes owing to normal MAPK signaling within the 
granulosa cell compartment. However, in vitro culture of fertilized oocytes showed progressively 
higher rate of embryonic death with each cleavage. Analysis of MI and MII stage oocytes 
demonstrated severe spindle defects with large, spread out spindles, misaligned chromosomes, 
disrupted MTOCs at spindle poles and abnormally large polar bodies.  
The extrusion of large polar bodies from oocytes with Erk deletion proved to be an interesting 
phenomenon as it showed us that early embryonic death in the absence of ERKs might be due to 
multiple factors. In addition to disrupted spindle assembly leading to improper segregation of 
chromosomes, it can also be inferred that ERKs play a role in migration of the spindle within the 
oocyte. This event is essential in oocyte division as it ensures the asymmetric division 
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characteristic of the anisogenic gametogeneis seen in mammals. Absence of asymmetry during 
oocgenesis means that large polar bodies, when extruded take away with them much of the 
cytoplasmic content kept as reserve for future embryo development. Since oocytes are believed 
to transcriptionally silent at this stage, it is not possible to restore the cytoplasmic milieu by 
protein synthesis. 
The next step was to analyze the cause of severe spindle defects in the Erk deleted oocytes. 
Perhaps the most surprising finding came when I examined downstream targets of ERK1/2 in our 
wildtype and DKO oocytes.  Unexpectedly, RSK, the canonical target of ERKs, was shown to be 
unaffected the DKO oocytes.  Instead, upon examination of the phosphorylation profiles of the 
other various MAPK activated kinases, phosphorylation of MSK1 (Mitogen and Stress activated 
Kinase 1) was found to be absent.  Not much is known about the function of MSK1 in the 
mammalian oocyte. It is believed to be involved in EMI2 phosphorylation during MII arrest, an 
event that is critical for maintenance of MII arrest.  However, since we did not observe 
spontaneous release of MII arrest in the Erk1/2 DKO oocytes, EMI2 did not seem to be a likely 
target. it is also possible that MSK1, owing to its localization on the spindle microtubules, has 
more than target on the spindle assembly itself.  
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In ES cells MSK1 phosphorylates Histone H3 in an ERK mediated pathway to bring about 
differentiation (Lee, McCool et al. 2006). Analysis of histone H3 in oocytes revealed an overall 
reduction in phosphorylation levels of Histone H3 at specifically Serine 10 (H3S10). This result 
is particularly interesting as H3S10 phosphorylation in somatic cells is more commonly 
associated with Aurora Kinase activity, and brings about chromatin condensation during mitosis 
(Sawicka and Seiser 2012). Disruption of H3 phosphorylation at S10 reduces access of 
condensation factors to chromatin leading to uncondensed chromosomes at metaphase. Improper 
condensation disrupts bipolar spindle formation by affecting the tension exerted at the 
kinetochores by microtubules and can result in spindle defects.   Since an abnormal spindle is the 
primary phenotype of the Erk1/2 DKO oocyte, it can be inferred that reduction in Histone H3 
phosphorylation is responsible for uncondensed chromatin and hence, the spindle defects. 
However, this is the first time that histone mediated spindle defects are being demonstrated to 
occur via the ERK-MSK1 cascade in mammalian oocytes (Figure 1). 
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Figure 5.1. Model for downstream events of the ERK/MAPK cascade in spindle assembly. 
Downstream signaling events of the ERK pathway produces modification of histones via the 
action of the ERK activated kinase, MSK1. Histone H3 modification by phosphorylation brings 
about chromatin condensation. Proper condensation of chromatin ensures bipolar attachment of 
the spindle microtubules onto the kinetochores of chromosomes (K-MT). Correct placement of 
the microtubules is required to maintain the spindle tension that then signals accurate formation 
of the metaphase spindle which, in turn precipitates timely entry into anaphase.  
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Nonetheless the effects of MSK1 mediated H3S10 phosphorylation on transcriptional control 
have yet to be studied in the oocyte. MII stage oocytes are believed to be transcriptionally silent, 
so it will be interesting to see if the ERK-MSK1-H3S10 cascade induces any transcriptional 
changes within the oocyte before or after fertilization. In addition to transcriptional activity, the 
translational activity is also likely to be affected in the absence of ERKs owing to the likelihood 
of ERKs being involved in translation and post-translational modifications. In order to study all 
these changes, analysis of the phosphoproteome and transcriptome of the whole oocyte is 
essential. 
Assessment of the whole proteome of the oocyte is important because of two factors- (a) As 
established before, formation of large less compact spindles and improper migration of the 
spindle can cause extrusion of large polar bodies and Erk deletion in oocytes produce this 
phenotype. Assessment of the total protein content will help understand how protein loss with 
large polar bodies can affect embryonic development and the embryo protein reserve. It can also 
help in establishing a threshold value for total protein content required for embryo development. 
For the specific purpose of our research it would tell us how Erk deletion might bring about 
embryonic death. (b) It would shed light on the very important question of how involved MAPK 
pathway is in transcription and protein production within the oocyte.   
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Oocytes are cells with a highly complex store of proteins, RNAs, lipids and other small 
molecules required for the development and early embryonic survival. The most in-depth 
analysis to date on the oocyte proteome show the presence of approximately 4000 distinct 
proteins in the Metaphase II oocyte cytosol (Pfeiffer, Siatkowski et al. 2011). Comparison of 
oocyte at different stages of meiotic progression (GV, MI and MII) have revealed that the total 
peptide content of oocyte become progressively higher with each stage (Wang, Kou et al. 2010). 
This indicates that oocyte is transcriptionally and translationally active prior to MII and that the 
proteome of oocytes is dynamic. 
Compared with early embryos and ES cells, oocytes produce more proteins that are required for 
post-translational modification of other proteins (ARF family), maternal affector proteins (NLRP 
family), and ubiquitin degradation pathway (F-box family) (Wang, Kou et al. 2010). Specifically 
in the MII stage, proteins that are highly represented include transcription factors, translation 
proteins, DNA repair proteins, and proteins required for epigenetic modifications such as histone 
demethylases, methyl transferases etc. Among highly represented proteins are several MAP 
Kinases including ERK1 and ERK2, and several downstream transcription factors such as FAK1 
(Wang, Kou et al. 2010). Comparison of the protein content of the ERK depleted oocyte could 
give us a good idea on how important the ERKs are in the synthesis of proteins. 
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Another essential analysis to be performed on the Erk1/2 double knockout oocytes would be the 
whole transcriptome comparison with the intact oocytes. The most in-depth analysis of MII 
oocyte transcriptome has revealed an approximate total of 9000 transcripts (Bettegowda and 
Smith 2007). Many mRNA transcripts in the oocyte are believed to be translationally quiescent 
and mRNAs transcripts are stored in the oocyte cytoplasm as reserve to be translated during 
early embryonic cleavage and reprogramming in the embryo. However, the presence of mRNA 
transcripts of other proteins required for metabolic processes, transport and cellular component 
organization indicate that a constant turnover these proteins is occurring in the oocyte. 
Whether fated for immediate translation of embryo reserve or for immediate use, these mRNAs 
are transcribed in the oocyte during the follicular growth phase (Fair, Carter et al. 2007). Since 
ERK1 and ERK2 are absent at this stage in our Erk1/2 double knockout mutants, comparison of 
global transcriptome would help in delineating the role of ERK in transcriptional activity within 
the oocyte.  
Beyond the MII stage till the activation of the zygote genome there is believed to be no 
transcription within the oocyte. There is however, much post-translational modification of 
preexisting maternal mRNAs and proteins. Many of these modifications are brought about by 
alteration of the phosphorylation status of proteins. Several kinases and phosphatases are active 
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during this time. So far only a small set of phosphorylation events has been identified in the 
mammalian oocyte, most of which are in the context of meiotic resumption only. There is the 
need to define phosphoproteome at a more comprehensive level, identifying not only the status 
of phosphoproteins but also key sites of phosphorylation as well.  
Advances in mass screening methods such as metal ion chromatography have provided us with 
techniques to perform mass spectrometry analysis with enrichment of phosphorylated peptides. 
Studies performed using these techniques have proven to be veritable mines of information 
regarding phosphoproteome profiles of cells. For instance, the phosphoproteome analysis of 
Xenopus eggs just prior to embryo transcription revealed multiple simultaneous phosphorylations 
on closely spaced residues on proteins that were previously unknown (Vernos, Heasman, et al. 
1993). Another study using a mass spectrometry based analysis of the human mitotic spindle 
identified an approximate 300 previously unknown phosphorylations on established spindle 
proteins and an approximate 400 phosphorylation sites on other proteins providing further 
insights into the temporal regulation of a mitotic spindle.  
In chapter 4, I examined other possible downstream targets of ERK by performing a mass 
spectrometry analysis of proteins separated with a phosphorylation specific antibody MPM2. 
MPM2 detects the specific type of serine/ threonine phosphorylations that are characteristic of 
	  	  
161	  
ERK activity. The protein signatures that got resolved were screened based on number of protein 
hits, presence and number of S/T sites and molecular weight. Of the selected proteins, several 
interesting ones showed involvement in spindle formation, assembly and function (Table 1). 
 
Table 5.1. Selected proteins with ERK-specific phosphorylations from MS analysis of 
oocytes. 
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One such protein with the highest number of hits and a very high number of S/T sites, TACC3, 
was selected for further analysis. However, experiments to detect its presence in the oocyte did 
not show conclusive results possibly because of unspecific antibodies. Nevertheless it would be 
interesting to look at the interaction between TACC3 and ERK1/2 in vitro to assess the 
phosphorylation activity of latter. It would also be exciting to look at the function of other 
interesting proteins of which I mentioned in chapter 3.  Comparison of the phosphorylation status 
of these proteins during MII in the Erk1/2DKO oocytes with its wild type counterpart would 
reveal more information on the function of ERK1 and 2. 
One other interesting aspect of this project is the spindle assembly checkpoint that I have 
discussed in Chapter 4. I had hypothesized that since spindle defects are numerous in the Erk1/2 
DKO oocyte, the SAC proteins would be activated and localized in the spindle. However SAC 
protein localization showed very inconclusive results indicating that either the antibodies were 
not specific or that SAC fails to be activated in the absence of ERKs and hence there is no 
regulation of spindle assembly in these oocytes leading to chromosome segregation defects and 
aneuploidy in the embryo. A much more thorough investigation is required to better understand 
how the SAC function is affected by the absence of MAPKs. 
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Conclusions  
ERKs are some of the most significant signaling molecules with involvement in almost all major 
cell cycle events. There is a growing body of evidence to support the importance of ERK 
signaling pathways in gametogenesis. This is especially true of the oocyte where, there is much 
information showing that MAPK signaling and meiotic resumption are strongly coupled. 
However, not much is known about the roles of ERKs beyond meiotic resumption in the oocyte. 
While disruption of ERK signaling has certainly been reported to produce spindle and 
cytoskeletal defects, the actual mechanism by which these effects are produced are not known. 
Exact downstream mechanism(s) have yet to be delineated. The work described in this thesis 
attempts to increase our understanding of specific effector pathways of ERKs on cell cycle 
progression and cytokinesis in the oocyte. This study provides a global hypothesis of the action 
of ERK signaling in the oocyte, namely, the temporal and spatial organization of cellular 
machinery to convert a diploid germ cell to a haploid oocyte. Here I have demonstrated that 
ERKs play a pivotal role in ensuring chromosome segregation and asymmetric division of the 
oocyte.  
However, the results of this study uncover only a small part of the global picture of ERK 
involvement in gametogenesis. The exact mechanism of ERK action on important events in 
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gametogenesis such as primordial germ cell development, somatic cell interactions, sex 
differentiation, meiosis, early embryo development etc are poorly understood. The studies in this 
thesis will serve as a framework for exploration of these events described above as well as 
further downstream effects of ERKs on the whole proteome and transcriptome of the oocyte. 
This work will contribute towards a better understanding of the concerted mechanisms that bring 
about the change of a germ cell into a highly specialized oocyte capable of supporting new life as 
an embryo.  
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APPENDIX 1 
MS analysis from MPM2 IP from 130 and 80 KDa bands 
Wildtype oocytes (~1500 per replicate) were lysed, immunoprecipitated with MPM2 antibody and run on a 7% SDS-PAGE gel. 
Regions of the gel corresponding to 130 and 80 KDa were excised and used for Mass Spectrometry analysis. Results from MS assay 
presented as p130 or p80 (proteins from the 130 or 80 KDa bands respectively) from the first and second replicates. Column Titles 
explained below.  
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P130 1st replicate MS analysis Wildtype oocytes 
prot_hit_nu
m 
prot_acc prot_desc prot_score prot_mass prot_cover prot_pi emPAI molar % 
1 gi|1671656
9 
protease, 
serine, 1 
[Mus 
musculus] 
797 26802 12.2 4.75 1.56 10.071013
56 
2 gi|1129836
36 
keratin 
complex 1, 
acidic, 
gene 10 
[Mus 
musculus] 
582 57178 13.7 5 0.65 4.1962556
49 
3 gi|6756081 zona 
pellucida 
glycoprotei
n 2 [Mus 
musculus] 
557 81413 23.7 6.12 1.04 6.7140090
38 
4 gi|2148993
5 
keratin 14 
[Mus 
musculus] 
513 53176 17.4 5.1 0.72 4.6481601
03 
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5 gi|1261165
85 
keratin 
complex 2, 
basic, gene 
1 [Mus 
musculus] 
483 66079 5.2 8.39 0.55 3.5506778
57 
6 gi|3198159
6 
ubiquitin-
like, 
containing 
PHD and 
RING 
finger 
domains, 1 
[Mus 
musculus] 
470 89689 30.9 8.63 1.2 7.7469335
05 
7 gi|6680602 keratin 15 
[Mus 
musculus] 
421 49243 10 4.78 0.68 4.3899289
86 
8 gi|6680604 keratin 16 
[Mus 
musculus] 
382 51973 8.1 5.13 0.36 2.3240800
52 
9 gi|6756083 zona 
pellucida 
glycoprotei
n 3 [Mus 
musculus] 
347 47187 25.2 6.09 0.97 6.2621045
84 
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10 gi|4705901
3 
keratin 73 
[Mus 
musculus] 
292 59502 5.9 8.36 0.38 2.4531956
1 
11 gi|9468104
0 
transformin
g, acidic 
coiled-coil 
containing 
protein 3 
[Mus 
musculus] 
288 70767 18.4 4.56 0.8 5.1646223
37 
12 gi|9910294 keratin 71 
[Mus 
musculus] 
276 57860 5.9 6.6 0.39 2.5177533
89 
13 gi|5109229
3 
keratin 77 
[Mus 
musculus] 
269 61379 5.2 7.74 0.3 1.9367333
76 
14 gi|4767909
5 
keratin 42 
[Mus 
musculus] 
266 50488 15.5 5.05 0.37 2.3886378
31 
15 gi|1242490
92 
zona 
pellucida 
glycoprotei
n 1 [Mus 
musculus] 
231 69934 8.5 6.07 0.38 2.4531956
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16 gi|2091103
1 
keratin 5 
[Mus 
musculus] 
211 61957 12.6 7.59 0.36 2.3240800
52 
17 gi|8478177
1 
trypsin 10 
[Mus 
musculus] 
199 26888 14.6 5.5 0.6 3.8734667
53 
18 gi|1244874
19 
keratin 
complex 2, 
basic, gene 
17 [Mus 
musculus] 
171 71336 4.5 8.26 0.2 1.2911555
84 
19 gi|1492556
37 
PREDICTE
D: similar 
to Chain L, 
Structural 
Basis Of 
Antigen 
Mimicry In 
A Clinically 
Relevant 
Melanoma 
Antigen 
System 
isoform 1 
[Mus 
musculus] 
169 26430 11.8 5.13 0.61 3.9380245
32 
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20 gi|5087215
5 
NLR family, 
pyrin 
domain 
containing 
14 [Mus 
musculus] 
135 115738 6.8 6.06 0.18 1.1620400
26 
21 gi|5460717
1 
keratin 6A 
[Mus 
musculus] 
109 59641 7.4 8.04 0.31 2.0012911
56 
22 gi|1492637
52 
PREDICTE
D: similar 
to 
immunoglo
bulin 
gamma 2A 
chain [Mus 
musculus] 
100 46995 8.1 6.08 0.15 0.9683666
88 
23 gi|5192134
3 
hypothetica
l protein 
LOC43298
7 [Mus 
musculus] 
100 35315 9.6 5.09 0.43 2.7759845
06 
24 gi|2216477
6 
keratin 6L 
[Mus 
musculus] 
98 57802 5.6 7.55 0.18 1.1620400
26 
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25 gi|8570168
0 
keratin 76 
[Mus 
musculus] 
85 63319 4.7 8.68 0.22 1.4202711
43 
26 gi|3757412
1 
D10Ertd80
2e protein 
[Mus 
musculus] 
82 103935 1.6 8.23 0.03 0.1936733
38 
27 gi|1455806
29 
keratin 
Kb40 [Mus 
musculus] 
79 114018 1.1 8.36 0.03 0.1936733
38 
28 gi|3385950
6 
albumin 
[Mus 
musculus] 
76 70730 4.4 5.75 0.1 0.6455777
92 
29 gi|7104396
1 
trypsinoge
n 7 [Mus 
musculus] 
68 27089 4.9 8.22 0.12 0.7746933
51 
30 gi|1492555
78 
PREDICTE
D: similar 
to 
immunoglo
bulin kappa 
chain [Mus 
musculus] 
63 14630 9.9 8.53 0.23 1.4848289
22 
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31 gi|8875858
2 
pyridoxal-
dependent 
decarboxyl
ase 
domain 
containing 
1 isoform 1 
[Mus 
musculus] 
63 88136 1.4 5.31 0.04 0.2582311
17 
32 gi|2395609
6 
vesicle 
docking 
protein 
[Mus 
musculus] 
61 108000 3 4.85 0.06 0.3873466
75 
33 gi|3993041
3 
nucleopori
n 98 [Mus 
musculus] 
61 125014 6.9 5.98 0.14 0.9038089
09 
34 gi|1409720
11 
NALP, 
kappa 
[Mus 
musculus] 
58 110195 2.3 6.43 0.06 0.3873466
75 
35 gi|2956809
4 
kinesin 
family 
member 23 
[Mus 
musculus] 
52 109862 3.9 8.89 0.03 0.1936733
38 
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36 gi|9845265 ubiquitin A-
52 residue 
ribosomal 
protein 
fusion 
product 1 
[Mus 
musculus] 
47 15004 22.7 9.87 0.23 1.4848289
22 
37 gi|1204449
12 
poly (ADP-
ribose) 
glycohydrol
ase [Mus 
musculus] 
44 109853 1.5 6.39 0.03 0.1936733
38 
38 gi|5722227
6 
a 
disintegrin 
and 
metalloprot
einase 
domain 6-
like [Mus 
musculus] 
39 87804 1.5 7.96 0.04 0.2582311
17 
39 gi|8570172
4 
hypothetica
l protein 
LOC10299
1 [Mus 
musculus] 
38 49578 3.8 9.59 0.07 0.4519044
54 
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40 gi|1492749
56 
PREDICTE
D: similar 
to 
hCG20389
26 [Mus 
musculus] 
38 19110 8.9 4.9 0.18 1.1620400
26 
41 gi|2736964
6 
TBC1 
domain 
family, 
member 25 
[Mus 
musculus] 
38 82949 1.2 6.31 0.04 0.2582311
17 
42 gi|5678543
0 
disabled 
homolog 2 
isoform b 
[Mus 
musculus] 
37 58800 3.8 5.66 0.11 0.7101355
71 
43 gi|5036323
2 
nestin [Mus 
musculus] 
34 207627 0.5 4.3 0.02 0.1291155
58 
44 gi|1952710
0 
oxysterol 
binding 
protein-like 
9 isoform a 
[Mus 
musculus] 
34 63062 2 5.89 0.05 0.3227888
96 
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45 gi|1492531
87 
PREDICTE
D: 
retinoblast
oma-
associated 
factor 600 
isoform 1 
[Mus 
musculus] 
34 578883 0.2 5.72 0.01 0.0645577
79 
46 gi|2715174
4 
SH3-
domain 
kinase 
binding 
protein 1 
[Mus 
musculus] 
34 68949 1.6 7.05 0.05 0.3227888
96 
47 gi|5803739
7 
zinc finger 
protein 509 
[Mus 
musculus] 
32 84862 0.7 7.99 0.04 0.2582311
17 
48 gi|2145028
7 
cold shock 
domain 
containing 
E1, RNA 
binding 
[Mus 
musculus] 
30 89590 0.8 5.97 0.04 0.2582311
17 
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49 gi|1259875
99 
CD2-
associated 
protein 
[Mus 
musculus] 
30 70578 1.6 6.07 0.05 0.3227888
96 
50 gi|8437036
1 
nidogen 2 
[Mus 
musculus] 
27 156610 0.6 5.16 0.02 0.1291155
58 
51 gi|6671682 caspase 11 
[Mus 
musculus] 
24 43356 2.7 6.61 0.08 0.5164622
34 
       15.49 100 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  	  
194	  
P80 1st replicate MS analysis Wildtype oocytes 
prot_hit_n
um 
prot_acc prot_desc prot_score prot_mass prot_cover prot_pi emPAI molar %  
1 gi|167165
69 
protease, 
serine, 1 
[Mus 
musculus] 
782 26802 12.2 4.75 1.56 11.0  
2 gi|119372
294 
peptidyl 
arginine 
deiminase
, egg and 
embryo 
abundant 
[Mus 
musculus] 
620 77755 41.6 5.36 1.38 9.7  
3 gi|675608
3 
zona 
pellucida 
glycoprot
ein 3 
[Mus 
musculus] 
474 47187 27.6 6.09 1.58 11.1  
	  	  
195	  
4 gi|338595
06 
albumin 
[Mus 
musculus] 
436 70730 14.5 5.75 0.44 3.1  
5 gi|319816
90 
heat 
shock 
protein 8 
[Mus 
musculus] 
360 71055 30.3 5.37 0.88 6.2  
6 gi|112983
636 
keratin 
complex 
1, acidic, 
gene 10 
[Mus 
musculus] 
329 57178 13.7 5 0.85 6.0  
7 gi|126116
585 
keratin 
complex 
2, basic, 
gene 1 
[Mus 
musculus] 
313 66079 5.2 8.39 0.47 3.3  
8 gi|470590
13 
keratin 73 
[Mus 
musculus] 
221 59502 5.9 8.36 0.38 2.7  
	  	  
196	  
9 gi|209110
31 
keratin 5 
[Mus 
musculus] 
217 61957 10.5 7.59 0.36 2.5  
10 gi|124487
419 
keratin 
complex 
2, basic, 
gene 17 
[Mus 
musculus] 
183 71336 4.5 8.26 0.25 1.8  
11 gi|214899
35 
keratin 14 
[Mus 
musculus] 
174 53176 9.1 5.1 0.43 3.0  
12 gi|847817
71 
trypsin 10 
[Mus 
musculus] 
160 26888 14.6 5.5 0.6 4.2  
13 gi|668060
2 
keratin 15 
[Mus 
musculus] 
152 49243 7.5 4.78 0.57 4.0  
14 gi|546071
71 
keratin 6A 
[Mus 
musculus] 
141 59641 5.8 8.04 0.31 2.2  
	  	  
197	  
15 gi|519213
43 
hypothetic
al protein 
LOC4329
87 [Mus 
musculus] 
136 35315 9.6 5.09 0.57 4.0  
16 gi|167165
83 
transduci
n-like 
enhancer 
protein 6 
[Mus 
musculus] 
123 65930 14.6 5.67 0.28 2.0  
17 gi|133862
38 
keratin 34 
[Mus 
musculus] 
114 46185 9.2 4.76 0.23 1.6  
18 gi|476790
95 
keratin 42 
[Mus 
musculus] 
105 50488 6.2 5.05 0.21 1.5  
	  	  
198	  
19 gi|675608
1 
zona 
pellucida 
glycoprot
ein 2 
[Mus 
musculus] 
95 81413 5.8 6.12 0.17 1.2  
20 gi|943675
94 
PREDICT
ED: 
similar to 
orthologu
e of H. 
sapiens 
chromoso
me 20 
open 
reading 
frame 119 
(C20orf11
9) [Mus 
musculus] 
95 64975 8.5 8.32 0.28 2.0  
21 gi|145580
629 
keratin 
Kb40 
[Mus 
musculus] 
87 114018 1.3 8.36 0.06 0.4  
	  	  
199	  
22 gi|839368
4 
keratin 35 
[Mus 
musculus] 
87 48984 8.2 4.76 0.3 2.1  
23 gi|710439
61 
trypsinog
en 7 [Mus 
musculus] 
79 27089 4.9 8.22 0.12 0.8  
24 gi|399304
27 
myotubul
arin 
related 
protein 14 
[Mus 
musculus] 
77 59799 7.4 6.18 0.17 1.2  
25 gi|857016
80 
keratin 76 
[Mus 
musculus] 
65 63319 3 8.68 0.16 1.1  
26 gi|319808
32 
keratin 
complex 
2, basic 
gene 18 
[Mus 
musculus] 
64 57377 5.5 6.19 0.12 0.8  
	  	  
200	  
27 gi|829331
44 
PREDICT
ED: 
coiled-coil 
domain 
containing 
6 isoform 
1 [Mus 
musculus] 
63 53077 7.5 6.87 0.13 0.9  
28 gi|675448
2 
keratin 18 
[Mus 
musculus] 
57 47475 5.9 5.22 0.14 1.0  
29 gi|675425
6 
heat 
shock 
protein 9 
[Mus 
musculus] 
50 73768 1.6 5.91 0.04 0.3  
30 gi|273697
82 
gem 
(nuclear 
organelle) 
associate
d protein 
5 [Mus 
musculus] 
47 169080 0.5 6.25 0.02 0.1  
	  	  
201	  
31 gi|743159
85 
keratin 
complex 
2, basic, 
gene 10 
[Mus 
musculus] 
46 55098 3.7 5.63 0.12 0.8  
32 gi|149255
637 
PREDICT
ED: 
similar to 
Chain L, 
Structural 
Basis Of 
Antigen 
Mimicry In 
A 
Clinically 
Relevant 
Melanom
a Antigen 
System 
isoform 1 
[Mus 
musculus] 
41 26430 5.9 5.13 0.13 0.9  
	  	  
202	  
33 gi|179986
94 
fragile X 
mental 
retardatio
n gene 1, 
autosoma
l homolog 
[Mus 
musculus] 
38 61178 1.5 6.02 0.05 0.4  
34 gi|216246
17 
RIKEN 
cDNA 
1110007
M04 [Mus 
musculus] 
37 20070 4 9.4 0.17 1.2  
35 gi|572222
76 
a 
disintegrin 
and 
metallopr
oteinase 
domain 6-
like [Mus 
musculus] 
36 87804 1.5 7.96 0.04 0.3  
	  	  
203	  
36 gi|984526
5 
ubiquitin 
A-52 
residue 
ribosomal 
protein 
fusion 
product 1 
[Mus 
musculus] 
35 15004 12.5 9.87 0.23 1.6  
37 gi|503632
32 
nestin 
[Mus 
musculus] 
34 207627 0.5 4.3 0.02 0.1  
38 gi|149253
187 
PREDICT
ED: 
retinoblas
toma-
associate
d factor 
600 
isoform 1 
[Mus 
musculus] 
33 578883 0.2 5.72 0.01 0.1  
	  	  
204	  
39 gi|580373
97 
zinc finger 
protein 
509 [Mus 
musculus] 
32 84862 0.7 7.99 0.04 0.3  
40 gi|217461
57 
arylforma
midase 
[Mus 
musculus] 
32 34322 3.6 5.72 0.1 0.7  
41 gi|214502
87 
cold 
shock 
domain 
containing 
E1, RNA 
binding 
[Mus 
musculus] 
31 89590 0.8 5.97 0.04 0.3  
	  	  
205	  
42 gi|149234
349 
PREDICT
ED: 
centroso
me-
associate
d protein 
350 
isoform 1 
[Mus 
musculus] 
31 348035 0.3 6 0.01 0.1  
43 gi|283950
18 
junction 
plakoglobi
n [Mus 
musculus] 
31 82490 2.6 5.75 0.04 0.3  
44 gi|134948
762 
protein 
tyrosine 
phosphat
ase, non-
receptor 
type 13 
[Mus 
musculus] 
29 271947 0.5 5.93 0.01 0.1  
	  	  
206	  
45 gi|305200
43 
hypothetic
al protein 
LOC2107
57 [Mus 
musculus] 
29 73362 1.6 5.77 0.04 0.3  
46 gi|136260
40 
A kinase 
(PRKA) 
anchor 
protein 
(gravin) 
12 [Mus 
musculus] 
26 181156 1 4.39 0.02 0.1  
47 gi|667168
2 
caspase 
11 [Mus 
musculus] 
26 43356 2.7 6.61 0.08 0.6  
       14.21 100  
 
 
 
 
 
 
 
	  	  
207	  
 
P130 2nd replicate MS analysis Wildtype oocytes 
prot_hit_nu
m 
prot_acc prot_desc prot_score prot_mass prot_cover prot_pi emPAI molar % 
1 gi|1129836
36 
keratin 
complex 1, 
acidic, 
gene 10 
[Mus 
musculus] 
334 57178 9.8 5 0.4 2.57 
2 gi|1671656
9 
protease, 
serine, 1 
[Mus 
musculus] 
333 26802 8.1 4.75 0.6 3.85 
3 gi|2839501
8 
junction 
plakoglobin 
[Mus 
musculus] 
289 82490 12.8 5.75 0.37 2.38 
4 gi|9468104
0 
transformin
g, acidic 
coiled-coil 
containing 
protein 3 
[Mus 
musculus] 
273 70767 12.5 4.56 0.44 2.83 
	  	  
208	  
5 gi|1261165
85 
keratin 
complex 2, 
basic, gene 
1 [Mus 
musculus] 
244 66079 4.9 8.39 0.34 2.18 
6 gi|2148993
5 
keratin 14 
[Mus 
musculus] 
230 53176 14.3 5.1 0.35 2.25 
7 gi|3385950
6 
albumin 
[Mus 
musculus] 
203 70730 4.4 5.75 0.2 1.28 
8 gi|4705901
3 
keratin 73 
[Mus 
musculus] 
195 59502 5.6 8.36 0.24 1.54 
9 gi|4767909
5 
keratin 42 
[Mus 
musculus] 
177 50488 11.7 5.05 0.29 1.86 
10 gi|2924417
6 
hypothetica
l protein 
4732456N
10 [Mus 
musculus] 
155 58629 7.6 8.47 0.24 1.54 
11 gi|2091103
1 
keratin 5 
[Mus 
musculus] 
150 61957 9.1 7.59 0.3 1.93 
	  	  
209	  
12 gi|8478177
1 
trypsin 10 
[Mus 
musculus] 
146 26888 10.6 5.5 0.6 3.85 
13 gi|3162130
7 
desmoglein 
4 [Mus 
musculus] 
139 115915 3.9 4.58 0.12 0.77 
14 gi|3198083
2 
keratin 
complex 2, 
basic gene 
18 [Mus 
musculus] 
131 57377 9.5 6.19 0.25 1.61 
15 gi|1244874
19 
keratin 
complex 2, 
basic, gene 
17 [Mus 
musculus] 
131 71336 4.2 8.26 0.09 0.58 
16 gi|9790161 plakophilin 
1 [Mus 
musculus] 
130 82270 5.6 9.15 0.12 0.77 
17 gi|2135742
5 
keratin 82 
[Mus 
musculus] 
128 58673 5.4 5.99 0.24 1.54 
	  	  
210	  
18 gi|1103474
02 
DNA 
methyltran
sferase 
(cytosine-
5) 1 [Mus 
musculus] 
124 185372 2.8 7.92 0.07 0.45 
19 gi|1338623
8 
keratin 34 
[Mus 
musculus] 
116 46185 9.2 4.76 0.23 1.48 
20 gi|1492624
35 
PREDICTE
D: keratin 
complex 1, 
acidic, 
gene 3 
[Mus 
musculus] 
113 55405 10.7 5.21 0.19 1.22 
21 gi|8393684 keratin 35 
[Mus 
musculus] 
109 48984 8.5 4.76 0.22 1.41 
22 gi|2136120
9 
histone 
cluster 2, 
H4 [Mus 
musculus] 
109 11360 29.1 11.36 1.89 12.14 
23 gi|1340236
62 
stratifin 
[Mus 
musculus] 
108 27803 16.5 4.72 0.41 2.63 
	  	  
211	  
24 gi|8295014
9 
PREDICTE
D: 
desmoplaki
n isoform 2 
[Mus 
musculus] 
97 263538 2.9 6.53 0.04 0.26 
25 gi|6680604 keratin 16 
[Mus 
musculus] 
92 51973 6.6 5.13 0.2 1.28 
26 gi|7104396
1 
trypsinoge
n 7 [Mus 
musculus] 
88 27089 4.9 8.22 0.12 0.77 
27 gi|2079990
7 
histone 2, 
H2aa1 
[Mus 
musculus] 
82 14087 34.6 10.9 0.91 5.84 
28 gi|9845257 histone 1, 
H1c [Mus 
musculus] 
82 21254 15.6 11 0.55 3.53 
29 gi|5192134
3 
hypothetica
l protein 
LOC43298
7 [Mus 
musculus] 
81 35315 9.3 5.09 0.31 1.99 
	  	  
212	  
30 gi|3198172
2 
heat shock 
70kD 
protein 5 
(glucose-
regulated 
protein) 
[Mus 
musculus] 
80 72492 3.8 5.01 0.09 0.58 
31 gi|1455806
29 
keratin 
Kb40 [Mus 
musculus] 
79 114018 1.1 8.36 0.03 0.19 
32 gi|9845265 ubiquitin A-
52 residue 
ribosomal 
protein 
fusion 
product 1 
[Mus 
musculus] 
78 15004 24.2 9.87 0.51 3.28 
33 gi|2216477
6 
keratin 6L 
[Mus 
musculus] 
78 57802 3.6 7.55 0.12 0.77 
34 gi|3156068
6 
heat shock 
protein 2 
[Mus 
musculus] 
74 69884 3.8 5.51 0.1 0.64 
	  	  
213	  
35 gi|1492556
37 
PREDICTE
D: similar 
to Chain L, 
Structural 
Basis Of 
Antigen 
Mimicry In 
A Clinically 
Relevant 
Melanoma 
Antigen 
System 
isoform 1 
[Mus 
musculus] 
73 26430 8 5.13 0.27 1.73 
36 gi|1260323
29 
eukaryotic 
translation 
elongation 
factor 1 
alpha 1 
[Mus 
musculus] 
69 50424 6.1 9.1 0.21 1.35 
37 gi|6756081 zona 
pellucida 
glycoprotei
n 2 [Mus 
musculus] 
67 81413 4.5 6.12 0.13 0.83 
	  	  
214	  
38 gi|6755358 ribosomal 
protein L8 
[Mus 
musculus] 
65 28235 4.3 11.03 0.12 0.77 
39 gi|5035569
2 
lamin A 
isoform A 
[Mus 
musculus] 
58 74540 1.5 6.54 0.04 0.26 
40 gi|3198114
7 
leucine 
aminopepti
dase 3 
[Mus 
musculus] 
58 56549 2.3 7.14 0.06 0.39 
41 gi|6679439 peptidylprol
yl 
isomerase 
A [Mus 
musculus] 
57 18131 5.5 7.74 0.19 1.22 
42 gi|1492669
91 
PREDICTE
D: 
hypothetica
l protein 
isoform 1 
[Mus 
musculus] 
52 38550 8.5 5.02 0.18 1.16 
	  	  
215	  
43 gi|1240015
82 
melanoma 
inhibitory 
activity 3 
[Mus 
musculus] 
51 214171 1.5 4.68 0.02 0.13 
44 gi|9453687
0 
WNK 
lysine 
deficient 
protein 
kinase 2 
[Mus 
musculus] 
50 220018 1.1 5.45 0.01 0.06 
45 gi|3156056
0 
ribosomal 
protein SA 
[Mus 
musculus] 
49 33008 4.4 4.8 0.1 0.64 
46 gi|6680027 glutamate 
dehydroge
nase 1 
[Mus 
musculus] 
47 61640 3.6 8.05 0.11 0.71 
47 gi|2831676
0 
histone 1, 
H2bb [Mus 
musculus] 
46 13944 14.3 10.31 0.55 3.53 
	  	  
216	  
48 gi|9507079 selenium 
binding 
protein 2 
[Mus 
musculus] 
44 53165 2.1 5.78 0.06 0.39 
49 gi|6678465 tubulin, 
alpha 1a 
[Mus 
musculus] 
43 50612 5.3 4.97 0.07 0.45 
50 gi|1259875
99 
CD2-
associated 
protein 
[Mus 
musculus] 
42 70578 2 6.07 0.05 0.32 
51 gi|7106379 NACHT, 
leucine rich 
repeat and 
PYD 
containing 
5 isoform a 
[Mus 
musculus] 
42 127759 1.7 5.57 0.03 0.19 
	  	  
217	  
52 gi|1492590
85 
PREDICTE
D: similar 
to 
ribosomal 
protein 
isoform 1 
[Mus 
musculus] 
40 16723 7.7 10.96 0.2 1.28 
53 gi|9790163 plakophilin 
3 [Mus 
musculus] 
39 87758 1.4 9.43 0.04 0.26 
54 gi|1193722
94 
peptidyl 
arginine 
deiminase, 
egg and 
embryo 
abundant 
[Mus 
musculus] 
39 77755 1.8 5.36 0.04 0.26 
55 gi|8801472
0 
karyopheri
n (importin) 
beta 1 
[Mus 
musculus] 
38 98377 1.4 4.68 0.03 0.19 
	  	  
218	  
56 gi|6671509 actin, beta, 
cytoplasmi
c [Mus 
musculus] 
38 42052 12.5 5.29 0.25 1.61 
57 gi|2084698
6 
PREDICTE
D: similar 
to 
ribosomal 
protein S25 
[Mus 
musculus] 
37 13814 8 10.06 0.25 1.61 
58 gi|8374512
0 
ribosomal 
protein, 
large P2 
[Mus 
musculus] 
36 11644 13.9 4.42 0.3 1.93 
59 gi|5803737
7 
leucine rich 
repeat 
containing 
15 [Mus 
musculus] 
35 65048 2.8 5.96 0.05 0.32 
60 gi|6680159 H3 histone, 
family 3A 
[Mus 
musculus] 
35 15376 11.8 11.27 0.22 1.41 
	  	  
219	  
61 gi|3198110
0 
ribosomal 
protein S14 
[Mus 
musculus] 
35 16434 7.3 10.07 0.21 1.35 
62 gi|1492641
87 
PREDICTE
D: 
hypothetica
l protein 
[Mus 
musculus] 
35 100771 0.8 5.55 0.03 0.19 
63 gi|6756083 zona 
pellucida 
glycoprotei
n 3 [Mus 
musculus] 
34 47187 2.1 6.09 0.07 0.45 
64 gi|3052004
3 
hypothetica
l protein 
LOC21075
7 [Mus 
musculus] 
33 73362 1.6 5.77 0.04 0.26 
65 gi|2142689
3 
histone 1, 
H1b [Mus 
musculus] 
33 22562 4.9 10.91 0.15 0.96 
	  	  
220	  
66 gi|1492619
40 
PREDICTE
D: alpha-2-
plasmin 
inhibitor 
[Mus 
musculus] 
32 224236 0.6 5.69 0.01 0.06 
67 gi|1482770
39 
alpha-2-
macroglob
ulin 
precursor 
[Mus 
musculus] 
30 165674 0.9 6.18 0.02 0.13 
68 gi|3198159
6 
ubiquitin-
like, 
containing 
PHD and 
RING 
finger 
domains, 1 
[Mus 
musculus] 
29 89689 1.9 8.63 0.04 0.26 
69 gi|7305119 G two S 
phase 
expressed 
protein 1 
[Mus 
musculus] 
28 79160 1.2 9.45 0.04 0.26 
	  	  
221	  
70 gi|6755891 protease, 
serine, 3 
[Mus 
musculus] 
27 26851 8.1 4.84 0.12 0.77 
71 gi|6671682 caspase 11 
[Mus 
musculus] 
25 43356 2.7 6.61 0.08 0.51 
       15.57 100 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  	  
222	  
P80 2nd replicate MS analysis Wildtype oocytes 
prot_hit_nu
m 
prot_acc prot_desc prot_score prot_mass prot_cover prot_pi emPAI molar % 
1 gi|3385950
6 
albumin 
[Mus 
musculus] 
841 70730 9.9 5.75 0.31 4.03 
2 gi|1193722
94 
peptidyl 
arginine 
deiminase, 
egg and 
embryo 
abundant 
[Mus 
musculus] 
626 77755 30.5 5.36 1.02 13.26 
3 gi|1129836
36 
keratin 
complex 1, 
acidic, 
gene 10 
[Mus 
musculus] 
322 57178 10.9 5 0.4 5.20 
4 gi|2924417
6 
hypothetica
l protein 
4732456N
10 [Mus 
musculus] 
235 58629 5.6 8.47 0.24 3.12 
	  	  
223	  
5 gi|1671656
9 
protease, 
serine, 1 
[Mus 
musculus] 
227 26802 8.1 4.75 1.02 13.26 
6 gi|7106335 keratin 17 
[Mus 
musculus] 
217 48417 9 5 0.49 6.37 
7 gi|1261165
85 
keratin 
complex 2, 
basic, gene 
1 [Mus 
musculus] 
215 66079 4.9 8.39 0.34 4.42 
8 gi|5460717
1 
keratin 6A 
[Mus 
musculus] 
179 59641 9 8.04 0.31 4.03 
9 gi|2091103
1 
keratin 5 
[Mus 
musculus] 
178 61957 6.7 7.59 0.3 3.90 
10 gi|1342889
17 
dynein, 
cytoplasmi
c, heavy 
chain 1 
[Mus 
musculus] 
168 534447 0.3 6.03 0.01 0.13 
	  	  
224	  
11 gi|5192134
3 
hypothetica
l protein 
LOC43298
7 [Mus 
musculus] 
150 35315 9.3 5.09 0.43 5.59 
12 gi|3198169
0 
heat shock 
protein 8 
[Mus 
musculus] 
150 71055 16.1 5.37 0.25 3.25 
13 gi|1244874
19 
keratin 
complex 2, 
basic, gene 
17 [Mus 
musculus] 
142 71336 4.2 8.26 0.14 1.82 
14 gi|4767909
5 
keratin 42 
[Mus 
musculus] 
133 50488 6.4 5.05 0.37 4.81 
15 gi|5109229
3 
keratin 77 
[Mus 
musculus] 
127 61379 5.4 7.74 0.23 2.99 
16 gi|6680604 keratin 16 
[Mus 
musculus] 
124 51973 4.7 5.13 0.28 3.64 
	  	  
225	  
17 gi|7104396
1 
trypsinoge
n 7 [Mus 
musculus] 
123 27089 4.9 8.22 0.12 1.56 
18 gi|1455806
29 
keratin 
Kb40 [Mus 
musculus] 
121 114018 1.3 8.36 0.06 0.78 
19 gi|2216477
6 
keratin 6L 
[Mus 
musculus] 
108 57802 3.6 7.55 0.12 1.56 
20 gi|8293314
4 
PREDICTE
D: coiled-
coil domain 
containing 
6 isoform 1 
[Mus 
musculus] 
103 53077 10.7 6.87 0.2 2.60 
21 gi|6680606 keratin 19 
[Mus 
musculus] 
100 44515 9.2 5.28 0.15 1.95 
22 gi|2839501
8 
junction 
plakoglobin 
[Mus 
musculus] 
96 82490 2.7 5.75 0.08 1.04 
	  	  
226	  
23 gi|4055660
8 
heat shock 
protein 1, 
beta [Mus 
musculus] 
92 83571 2.2 4.97 0.08 1.04 
24 gi|8478177
1 
trypsin 10 
[Mus 
musculus] 
70 26888 10.6 5.5 0.26 3.38 
25 gi|9436759
4 
PREDICTE
D: similar 
to 
orthologue 
of H. 
sapiens 
chromoso
me 20 
open 
reading 
frame 119 
(C20orf119
) [Mus 
musculus] 
65 64975 4.3 8.32 0.1 1.30 
26 gi|1671658
3 
transducin-
like 
enhancer 
protein 6 
[Mus 
musculus] 
43 65930 5.3 5.67 0.05 0.65 
	  	  
227	  
27 gi|3041075
2 
hypothetica
l protein 
LOC24194
3 [Mus 
musculus] 
36 62199 1.5 8.95 0.05 0.65 
28 gi|3052004
3 
hypothetica
l protein 
LOC21075
7 [Mus 
musculus] 
34 73362 1.6 5.77 0.04 0.52 
29 gi|5803739
7 
zinc finger 
protein 509 
[Mus 
musculus] 
32 84862 0.7 7.99 0.04 0.52 
30 gi|1349487
62 
protein 
tyrosine 
phosphata
se, non-
receptor 
type 13 
[Mus 
musculus] 
32 271947 0.5 5.93 0.01 0.13 
31 gi|3042469
7 
genethonin 
1 [Mus 
musculus] 
30 36219 5.3 5.62 0.09 1.17 
	  	  
228	  
32 gi|2351025
9 
a 
disintegrin 
and 
metallopep
tidase 
domain 32 
[Mus 
musculus] 
30 86035 1.1 6.77 0.04 0.52 
33 gi|3198184
2 
3-hydroxy-
3-
methylgluta
ryl-
Coenzyme 
A synthase 
1 [Mus 
musculus] 
30 58160 5.8 5.65 0.06 0.78 
       7.69 100 
 
 
 
 
